The Online Seminar shows the Possibilities of the use of Desktop-Sharing Software. The Online-Seminar is free of charge an will contain the following topic.
How to Setup the Software.
Cost of the Software
Usage in the Sales and Marketing area.
The Webinar will held on request\, the duration is approx. 30 Minutes
Further Information to the Online-Seminar
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120104T000000Z DTEND;VALUE=DATE-TIME:20120104T020000Z UID:http://www.webinarcentral.net/content/bryant-stratton-college-online-virtual-open-house-3 URL;VALUE=URI:http://www.webinarcentral.net/content/bryant-stratton-college-online-virtual-open-house-3 SUMMARY:Bryant & Stratton College Online Virtual Open House DESCRIPTION:Join us on January 3rd\, between 6pm and 8pm EST for of our Open House to learn more about Bryant &\; Stratton College Online. Held in our online chat environment\, you can talk with our Admissions Representatives and learn more about the enrollment process. You can take this opportunity to ask questions about starting the college process\, how the online environment works as well as financial aid questions.
Fill out the quick and simple registration form and secure your spot in the open house. It’s free to everyone and there’s no obligation. Join us anytime between 6pm and 8pm EST to ask questions and get valuable information about taking the next steps towards earning your college degree.
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120105T051100Z DTEND;VALUE=DATE-TIME:20120105T051200Z UID:http://www.webinarcentral.net/content/cleaner-air-%E2%80%93-brighter-minds-indoor-air-quality-management-daycare-facilities URL;VALUE=URI:http://www.webinarcentral.net/content/cleaner-air-%E2%80%93-brighter-minds-indoor-air-quality-management-daycare-facilities SUMMARY:Cleaner Air – Brighter Minds\, Indoor Air Quality Management in Daycare Facilities. DESCRIPTION:We will explore the many facets of Indoor Air Quality and present easy ways to make the daycare environment healthier and safer for the children as well as the staff. Beat the sniffles\, runny noses\, stuffiness and potential long-term health effects with simple yet effective steps.
• What is Indoor Air Quality Management
• Sources of Poor IAQ
• How Pollutants Affect Children\, Caregivers\, Parents
• Simple\, Sound Solutions
• Air Cleaning Technologies
• Advantages of a Healthy Daycare Environment
• Benefits of Cleaner Air
Expectations for meaningful hazard analysis\, hazardous conditions\, and documentation have always existed by regulatory agencies.
There is an increased awareness of the importance of design activities to support the production of safe and effective product. Product risk management is a required tool to drive and direct resource constrained product design\, manufacture and validation activities in the company. High-profile field problems indicate that such activities are not yet adequately planned executed\, and visibility maintained. There is a failure to fully utilize the power of current risk management tools. Effective use of such risk management tools can help address the growing push by the public and the FDA\, to \\"toughen\\" its approach to product clearance and approval\, while reducing liability issues.
Why you should attend\: The U.S. FDA has stated that the use of a medical device or pharmaceuticals entails some degree of risk. In fact\, any medical procedure / intervention does. A manufacturer is responsible to identify those risks\, and take reasonable steps to mitigate them as far as practical and given the 'state of the art' at the time. ISO 14971 and ICH Q9 provide accepted methodologies by which to perform and document such an analysis and is accepted by the FDA. These activities can also be used as a method to train new hires\, especially in Marketing\, QA/RA\, Engineering\, and Manufacturing. This webinar will address the procedures\, provide and discuss suggested templates\, necessary to develop or modify and then use the ISO 14971 and Q9 models to perform and document such activities for any medical product. It will examine the additional actions necessary to make it a useful product reference\, CAPA\, root cause / failure investigation\, and validation prioritization\, and training tool\, and how to maintain it as a “living document”.
Areas Covered in the Session\:
The Revised ISO 14971\:2007/9 for Devices
ICH Q9 for Pharma
Product Hazard Analysis
Design\, Process\, and Use[r] Failure Mode\, Effects and Criticality Analysis
Fault Tree Analysis
Suggested Risk Management File / Report\, FMECA\, FTA Templates
The Team and It's Involvement – Who\, When and How
Using the Completed Document – It's Real Value \\"In the Loop\\"
Who Will Benefit\:
Senior Management in Drugs\, Devices\, Biologics\, Dietary Supplements
QA
RA
R&\;D
Engineering
Production
Operations
Consultants
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
1000 N West Street | Suite 1200 | Wilmington | DE | Zip 19801 | USA
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120108T180000Z DTEND;VALUE=DATE-TIME:20120108T180000Z UID:http://www.webinarcentral.net/content/product-risk-management-under-iso-14971-and-fda-ich-q9-webinar-globalcompliancepanel-0 URL;VALUE=URI:http://www.webinarcentral.net/content/product-risk-management-under-iso-14971-and-fda-ich-q9-webinar-globalcompliancepanel-0 SUMMARY:Product Risk Management Under ISO 14971 and FDA-ICH Q9 - Webinar By GlobalCompliancePanel DESCRIPTION:Expectations for meaningful hazard analysis\, hazardous conditions\, and documentation have always existed by regulatory agencies.
There is an increased awareness of the importance of design activities to support the production of safe and effective product. Product risk management is a required tool to drive and direct resource constrained product design\, manufacture and validation activities in the company. High-profile field problems indicate that such activities are not yet adequately planned executed\, and visibility maintained. There is a failure to fully utilize the power of current risk management tools. Effective use of such risk management tools can help address the growing push by the public and the FDA\, to \\"toughen\\" its approach to product clearance and approval\, while reducing liability issues.
Why you should attend\: The U.S. FDA has stated that the use of a medical device or pharmaceuticals entails some degree of risk. In fact\, any medical procedure / intervention does. A manufacturer is responsible to identify those risks\, and take reasonable steps to mitigate them as far as practical and given the 'state of the art' at the time. ISO 14971 and ICH Q9 provide accepted methodologies by which to perform and document such an analysis and is accepted by the FDA. These activities can also be used as a method to train new hires\, especially in Marketing\, QA/RA\, Engineering\, and Manufacturing. This webinar will address the procedures\, provide and discuss suggested templates\, necessary to develop or modify and then use the ISO 14971 and Q9 models to perform and document such activities for any medical product. It will examine the additional actions necessary to make it a useful product reference\, CAPA\, root cause / failure investigation\, and validation prioritization\, and training tool\, and how to maintain it as a “living document”.
Areas Covered in the Session\:
The Revised ISO 14971\:2007/9 for Devices
ICH Q9 for Pharma
Product Hazard Analysis
Design\, Process\, and Use[r] Failure Mode\, Effects and Criticality Analysis
Fault Tree Analysis
Suggested Risk Management File / Report\, FMECA\, FTA Templates
The Team and It's Involvement – Who\, When and How
Using the Completed Document – It's Real Value \\"In the Loop\\"
Who Will Benefit\:
Senior Management in Drugs\, Devices\, Biologics\, Dietary Supplements
QA
RA
R&\;D
Engineering
Production
Operations
Consultants
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
1000 N West Street | Suite 1200 | Wilmington | DE | Zip 19801 | USA
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120110T160000Z DTEND;VALUE=DATE-TIME:20120110T160000Z UID:http://www.webinarcentral.net/content/designing-and-implementing-dress-code-webinar-trainhr URL;VALUE=URI:http://www.webinarcentral.net/content/designing-and-implementing-dress-code-webinar-trainhr SUMMARY:Designing and Implementing a Dress Code - Webinar By TrainHR DESCRIPTION:Overview \: Whether you are designing a new dress code policy\, updating your current one or looking for suggestions how to implement your dress policy\, this webinar should give you clear guidelines.
Designing and implementing a dress code and dress policies for the workplace has become more complex today and should be addressed from many different angles\: from creating a professional image to promoting a safe environment. Both the reasons and benefits for having a policy will be addressed as well as how to meet the needs of a diverse workforce. Before deciding on a formal dress code or updating your current one\, many different approaches should be explored so that your decisions will promote a professional\, safe and comfortable environment that reflects your culture in a positive manner.
Why you should attend\: It will cover your reasons and rights as an employer to establish and enforce a dress code and how to develop and adopt one that complements your business. Considerations range from what is considered professional attire to cultural and generational preferences. We will discuss how to establish clear guidelines for employees\, the reasons behind decisions for dress and how to effectively and legally implement an effective and fair policy.
Areas Covered In the Session\:
Reasons to have a Dress Code
Your rights as an employer to establish a dress code as a condition of employment
What to include in your dress code
Defining business\, business casual and casual
Professionalism\: customer contact positions
Morale and respect among coworkers
Safety\: office and manufacturing positions
Uniforms and logo wear
Piercings\, tattoos and hair
Perfume and cologne
Hygiene
Cultural and religious considerations and other exceptions
Younger generations’ preference for informality
When companies have been taken to court about \\"dress\\"\: discrimination related to gender\, religion\, or race
When does dress make a positive or negative impact on performance
Designing a policy which corresponds to your business
Who will benefit\:
Chief Human Resource Officers
HR Managers\, Directors\, and Employee Relations Specialists
Employment Managers and Recruiters
Supervisors
Learning and Training Professionals
Affirmative Action Officers
Consultants and Business Owners
The webinar focuses on effective implementation of QRM through the understanding of the ICH Q9 process and principles of QRM. By reviewing the standard terminology of risk management and laying the foundation for a more practical approach to applying the QRM principles of ICH Q9 to any biopharmaceutical manufacturing process and equipment\, it enables you to speak the same \\"language of risk\\" as those of the regulators and thereby significantly reduces your companies exposure to audit failures.
Risk management activities involve processes\, methods\, and tools for identifying\, assessing and managing risks. These activities are conducted in a disciplined environment. It requires proactive decisions to continuously assess what could go wrong during the manufacturing of any product. This webinar addresses how to identify the critical risks and mitigate them. It provides a systemic prospective of QRM using the Swiss cheese model. Specifically\, it focuses on key factors for a successful Risk Management process\, the 7 key concepts in FDA's systems approach thinking to Risk Management\, the required QRM documents and their contents and Risk Assessment methods and tools.
The webinar aims to equip and empower attendees with the knowledge of basic risk management terminology\, the deployment of appropriate tools for risk assessment\, FDA's audit care about for QRM \, as well as how to apply risk management principles to various aspects of a quality system. Among the topics to be discussed are the key steps in the identification of risks\, establishing a scoring criteria to analyze identified risks\, use of the 5-p model for risk reduction\, risk acceptance basics including factors that establish a risk acceptability criteria\, elements of a Risk Control strategy and what and when to communicate with risk stakeholders. Since Risk Management is a dynamic process\, topics will also include how to continuously monitor risks and integrate them into a continual improvement strategy\, along with the management's role of ensuring the adherence to the strategy.
Why you should attend\: ICH Q8\, Q9 and Q10 have been the bedrock of the regulatory agencies' regulations for pharmaceutical cGMPs for the 21st century. While adoption of these has been slow\, some like Q9 and Q10 are increasingly coming into acceptance by the industry. Adoption of concepts such as Q8's QbD have been slow because it is still in its infancy and will require more time if it is to have the transformative effect first conceived by ICH. However\, QRM (Q9) and Quality Systems (Q10) are increasingly coming into acceptance by the industry since their understanding is not as intricate and complex as QbD is. It is becoming increasingly evident that application of QRM (Q9) techniques would provide the refinement tools to formulate and validate the QbD (Q8) models of the processes. Hence a good understanding and application of QRM techniques and tools would be instrumental in the development of realistic QbD models that are more reflective of true process characterization and actual process behavior.
The approach to quality and risk management is dynamic in nature due to the evolution of science and technology. This dynamic nature imposes a challenging situation for companies since they are now required to keep themselves fully trained and informed of the changing regulations. Additionally\, with the increasing formalization of QRM tools and techniques\, regulatory agencies are requiring companies to establish Quality Risk Management Plans that are being used as starting points for their audits. The requirement for performing QRM coupled with QRM's dynamic nature increases companies' risk of audit failures. Citations arising from such audit failures are being addressed through a consistent documentable approach to risk management throughout the company irrespective of the business and manufacturing processes. This webinar addresses the \\"common language of risk\\" coupled with the documentation strategy required to maintain a defensible risk control strategy to meet compliance requirements.
Areas Covered in the Session\:
Characteristics\, history &\; FDA’s involvement with QRM
In perspective\: QbD\, QRM and Quality systems
ICH Q9 Process
Principles of QRM
Key elements of QRM
Characteristics of QRM
Systemic processes and General Failure Types
7 Key concepts in FDA systems approach thinking
Swiss cheese model for systemic related safety
QRM documentation and their contents
Factors for a successful Risk Management process
Hazard\, Harm\, Risk concept
Key steps in risk identification
Use of scoring criteria and Heat Maps in analyzing and evaluating risks
Risk reduction and Risk acceptance basics
Factors that establish a Risk Acceptability criteria
QRM tools used\; their strengths and limitations
Selection of appropriate tools for different circumstances
Who Will Benefit\:
Project Managers\, Lead Engineers\, Software Engineers
Risk Managers and others Performing Risk Management Activities
Those involved in process improvement
Contractor\, Consultants Providing Engineering and Validation Services
QA\, Regulatory Affairs\, Engineering &\; IT personnel
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
This interactive webinar provides explicit details and live demonstration followed by a collaborative workshop that explains how to configure and validate a GxP compliant spreadsheet application.
What makes this session unique is the combination of step-by-step instructions and the hands on workings of each participant. Bring your laptop and use Excel for your own needs. This session will make you a better Excel user\, saving you time and costs.
Areas Covered in the Session\:
Develop spreadsheet applications that are GxP compliant.
Avoid 483s and warning letters.
What does and does not need to be validated.
Learn how to use Excel’s built in 21 CFR Part 11 features.
Apply features required for GxP environments without programming macros.
Validate your application with minimal documentation.
Follow along as we configure Excel for audit trails\, security features\, data verification\, and multiple concurrent users.
How to specify and test your application
Who Will Benefit\:
All Excel users
IT
QA
QC
Laboratory staff
Managers
Executives
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
During this webinar we will examine the DSM-IV diagnostic symptoms of Childhood Bipolar Disorder and review innovative research. Executive deficits and behavioral changes signaling the onset of the disorder will also be discussed.
Full Description\:
Diagnosing Childhood Bipolar Disorder and Treatment Strategies
During this one-hour webinar\, we will outline the DSM-IV diagnostic symptoms of bipolar disorder and review innovative research on bipolar disorder contrasted with a new DSM-IV diagnosis. Research on the sequelae of bipolar disorder\, including executive deficits\, will be described as well as the prodromal conditions and behavioral changes that signal the onset of childhood bipolar disorder. A probability nomogram\, a novel decision tool which improves the interpretation of family history and test data by diagnosing clinicians\, will be presented and discussed. Strategies by Dr. Miklowitz will be offered to support clinical and educational treatment options.
Course Includes\:
Live Q&\;A
Presentation Handout
Post session recording access
CE Credit
What You Will Learn\:
List the criteria for Bipolar I and Bipolar II from the DSM-IV
Discuss the work of Dr. Ellen Leibenluft related to Childhood Bipolar Disorder
Define the role of episodicity in Childhood Bipolar Disorder
Recognize the effects of Childhood Bipolar Disorder on the developing brain
Identify the prodromes for Childhood Bipolar Disorder
Your Presenter\:
ANITA REMIG\, Ed.D. F.P.P.R.\, F.S.M.I.\, is a practicing clinical psychologist and consultant specializing in learning styles\, brain-based research and learning problem interventions. Her articles have appeared in numerous publications including Child Study Journal\, Language and Speech and Journal of Child Psychology. Her papers have been presented to the American Educational Research Association\, American Psychological Association and the Society for Research in Child Development. Dr. Remig's national seminars include \\"The Human Brain and Learning Styles\,\\" \\"The Human Brain and Motivation\,\\" \\"ADHD and the Brain\,\\" \\"Learning Disabilities and ADHD\: Behavioral Interventions\\" and \\"Pervasive Developmental Disorder\: Autism\, Rett's\, CDD and Asperger's Disorder.\\" Dr. Remig is a member of the American Psychological Association and an instructor for the University of New Hampshire. She is a Fellow of the Prescribing Psychologist Register (F.P.P.R.) and a Fellow in Serious Mental Illness (F.S.M.I.) from the Prescribing Psychologist Register. Both fellowships are awarded by the International College of Prescribing Psychologists. Dr. Remig also passed the ICCP National Examination for Psychologists in Psychopharmacology.
Disclaimer\:
This event qualifies for one CE credit. Only registered attendees will have access to CE. A Cross Country Education web account is required to attend. There is no charge for a CCE web account. It is recommended that you join the meeting 15 to 20 minutes early. Speaker phone sound quality is poor and it is recommended that they not be used to listen to the event.
Technical requirements\:
To view this webinar you will need to download the WebEx Application. You will be prompted to download it when you first enter the site. To save time\, you can setup prior to the meeting by following this link\:
https\://apidemoeu.webex.com/apidemoeu/meetingcenter/mcsetup.php
Who Should Attend\:
Psychologists\, Psychiatrists\, Social Workers\, Counselors\, Case Managers\, Educators\, Marriage and Family Therapists\, Drug and Alcohol Abuse Counselors\, Physicians\, Nurses\, Nurse Practitioners\, Criminal Justice Personnel (Probation Officers)\, Occupational Therapists\, Certified Occupational Therapy Assistants\, Parents
The topic of supply chain integrity and security is relatively new in Pharma\, having gained prominence in recent years for the reasons described above. Breach of security related to criminal activity is where the issues are most visible and enforcement activity is actively taking place around the globe. In parallel\, if we are looking for sustainable\, root cause solutions\, we must also turn our attention to supply chain integrity and deal with both security and integrity concurrently.
An Oxford on-line dictionary definition of integrity is \\"the state of being whole and undivided\\". Over the last 40 years\, the Pharma supply chain has fragmented to the point where it is a million miles from that state. There are now multiple business models\, such as virtual\, biotech\, specialty Pharma\, innovator\, generics\, biosimilars\, etc and a divergence of supporting actors\, such a contract manufacturing organizations (CMOs)\, contract research organizations (CROs)\, central laboratories\, third party logistics providers\, pre-wholesalers\, wholesalers\, specialty pharmaceutical providers (SPPs) etc. As a result\, our supply chains have dis-integrated to the point where visibility and accountability have become blurred at the edges - and it is this disintegration that has opened the doors to criminal activity and errors in quality outcomes.
The solution is not an easy one. It requires urgent action to mitigate activities of the 'bad guys'\, together with a longer term approach to ensure the 'good guys' get better at building and managing robust supply chains. This can only be achieved by collaboration between regulators\, other enforcement agencies\, technology providers and the industry itself. Where do we start?
We must initially focus on the end-to-end supply chain in its current state. Chains of custody and ownership must be clearly identified and remediation actions agreed by responsible parties to plug the gaps that currently exist. For example\, Quality and technical agreements must become far more 'process' orientated so that they become working documents shared between business partners\, rather than merely a static list of tick boxes. Change control has to work on upstream and downstream impacts that might affect supply chain integrity and procurement must forge supply agreements that impose obligations for supply chain visibility on prospective partners. This and much more needs to happen and will be discussed in the session.
Then we must turn attention to the building of supply chains for the future - the product development phase. This industry is unique in that the entire supply chain must be registered with competent authorities before approval to sell and post-launch changes have to be approved. This places a great responsibility on getting it right from the start. This is where the opportunity lay for sustainable improvements in the physical architecture of the supply chain and the underpinning management processes and information flows. A foundation for this has already been put in place by the regulators through FDA's 21st Century Modernization initiative and ICH Q8 - 11 guidelines. The key to translating these initiatives into meaningful supply chain improvements\, however\, it in understanding the patient value proposition and the organizational/cultural elements that must firstly be in place\, and these are explored in some depth.
Why should you attend\: The Pharmaceutical supply chain has never been in such turmoil and under such attack from governments and regulators globally. The evidence is stark and mounting. Supply chain shortages in the US have moved even the President to demand urgent remediation\; high level congressional committees have also asked searching questions of FDA and other involved stakeholders\, in an attempt to discover what has been going on with high profile supply chain failures. Cargo theft\, diversion and counterfeiting have become almost endemic\, with detection and enforcement efforts stretched to the limit. Finally\, and possibly most worrying of all\, are the cases where materials have been adulterated or substituted with toxic alternatives (for economic gain) and have progressed undetected through one or more stages in the supply chain causing eventual patient death.
Areas Covered in the Session\:
How to organize for supply chain integrity throughout the product life cycle
Current approaches to clamping down on criminal activity in the supply chain
Issues causing greatest concern to regulators and how to address them
Role of ICH Q8 - 11 in building robust supply chains
How the disciplines of procurement and supply chain management (SCM) can be leveraged
Role of technology as an enabler
Who Will Benefit\:
Research chemistry and biochemistry
Chemical and biochemical engineering
Chemistry\, manufacturing\, and controls
Preclinical Development
Clinical Development
Regulatory Affairs
Quality Assurance
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
Why you should attend\:
The US Department of Health and Human Services (HHS)has begun\, in combination with consulting firm KPMG\, a program to meet requirements in the HITECH Act in the American Recovery and Reinvestment Act of 2009 (ARRA) for performing periodic audits of compliance with the HIPAA Privacy and Security Rules. In addition new enforcement is taking place related to the new HIPAA Breach Notification Rule. While in the past\, audits had been performed only at entities that had had a complaint filed against them\, the new rule calls for audits whether or not there is a complaint. This means that the HHS Office for Civil Rights (OCR) can show up at your door and ask to perform an audit on short notice\, and your organization will need to be ready.
If your organization is not ready\, the HIPAA rules have new\, significantly higher fines\, including mandatory minimum fines of $10\,000 for willful neglect of compliance. All HIPAA Covered Entities and Business Associates need to be fully in compliance and prepared for an audit at any time\, or risk the significant fines for non-compliance.
In addition\, HIPAA enforcement has taken on a new importance at HHS\, as shown in multi-million dollar fines and even a one million dollar settlement for a breach of just 192 records. HHS OCR officials have publicly stated that enforcement is now a priority\, and that means being ready for an audit is more important than ever. The \\"slap-on-the-wrist\\" days are over and fines and settlements are being levied\, with more on the way - don't let your organization be hit for an audit unprepared. And even postal inspectors are now using HIPAA to prosecute identity theft cases.
By using an information security management process\, those responsible for health information can develop the procedures and policies that can help prevent security problems\, and help prepare the organization for any incidents\, audits\, or enforcement actions.
If you don't take the proper steps to ensure your patients' health information is being protected according to the HIPAA Security and Privacy Rules\, you can be hit with significant fines and penalties. With the increased HIPAA fines beginning at $10\,000 in cases of willful neglect\, providing good information security and being in compliance are more important than ever.
Areas Covered in the Session\:
Fines and penalties for violations of the HIPAA regulations have been significantly increased and now include mandatory fines for willful negligence that begin at $10\,000 minimum.
HIPAA Audits have been few and far between in the past\, but that's now changing - the HHS is now auditing HIPAA covered entities and business associates even if there have been no complaints or problems reported.
Find out what HHS OCR is likely to ask you if you are selected for an audit\, and what you'll have to have prepared already when they do.
Find out what the rules are that you need to comply with and what policies you can adopt that can help you come into compliance.
Learn how the HIPAA rules have changed and how you may need to change how you work to keep up with them.
Learn how having a good compliance process can help you stay compliant more easily.
Find out what you'll need to have documented to survive an audit and avoid fines.
Find out what you'll need to think about to deal with future threats to the security of patient information.
Who Will Benefit\:
Compliance director
CEO
CFO
Privacy Officer
Security Officer
Information Systems Manager
HIPAA Officer
Chief Information Officer
Health Information Manager
Healthcare Counsel/lawyer
Office Manager
Price List\:
Live \: $195.00
Corporate live \: $695.00
Recorded \: $245.00
webinars@mentorhealth.com
http\://www.mentorhealth.com
Phone\: 800-447-9407
Fax\: 302-288-6884
This webinar will cover the process and benefits of using an empirical approach to design an optimized lyophilization cycle.
Optimized lyophilization cycle design can be an extremely difficult and daunting task for the scientist that is unskilled or under skilled in the process. This is becoming even more prevalent as many of the molecules coming out of discovery are more complex\, unstable\, and require a very specific\, multi component formulation to impart not only good chemical stability and physical stability to the active ingredient\, but also good physical stability to the dried solids themselves. Unfortunately\, many of the molecules that are used to help stabilize the chemical and physical stability of the active ingredient\, impart poor physical stability to the dried solids and can make lyophilization cycle design difficult. The development scientist who understands and can apply these principles\, will be much better equipped to develop robust cycles that can be used to produce quality products consistently\, in the shortest amount of time possible\, saving time and money. This webinar will start out with an introduction to thermal characterization including differential scanning calorimetry (DSC) and freeze-dry microscopy (FDM) and how the information gained from these techniques can be used as the foundation for optimized cycle design. Next\, the webinar will discuss\, in detail\, the process of designing the freezing\, primary\, annealing (if used)\, and secondary drying protocols for the cycle. In each case\, the process will be broken down to understand the correct choice of the different controllable lyopohilizer parameters including shelf temperature\, chamber pressure\, and hold times. Also discussed\, will be some of the specialized tools that can be used to aid the development scientist in cycle development including\, the sample thief\, the Pirani gauge\, and thermocouples.
Areas Covered in the Session\:
Thermal characterization including DSC and FDM
Understanding the effects of working with crystalline vs. amorphous components
The problem with working with a metastable glassy system and the use of annealing to correct this problem
Determining optimal shelf temperatures for the freezing step
Determining optimal shelf temperatures and chamber pressures for the primary drying step
Determining optimal shelf temperatures and chamber pressures for the secondary drying step
Characterization of the finished lyophilized product
Learning objectives\:
Learning how to interpret a lyophilization cycle chart
Developing optimal conditions for freezing\, primary\, and secondary drying
Distinguish between amorphous and crystalline components and how they affect cycle design
Understanding the need and techniques of characterizing the dried solids
Who Will Benefit\:
Quality Control Scientists
Development Scientists
Production Management
Quality Assurance
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
This webinar will examine the FDA's recently instituted annual \\"Strategic Priorities\\" initiative\, with emphasis on 2012.
Such a review will focus on the broad range of issues a company's senior management and QA/RA need to consider in their annual Management Review of their existing quality management system. This review takes on added urgency as a result of the stated intent of the Agency to get tougher across the board in its expectations for the medical industry and what the FDA and industry need to do internally. An additional review of recent information from the Agency\, other goals of the Agency that have already been translated into action in the past year will provide direction in areas of concern and what to expect in the future. This will be performed by a review of applicable FDA \\"Strategic Priorities\\" areas for required review or related industry problem areas. The result will be a basis for such a management review and a listing of likely milestones and tasks. Anticipation and addressing of weak spots proactively will further prove a company is \\"in control\\"\, assist in timely review of submissions to the Agency\, and in any remediation efforts.
Why you should attend\: Each year companies are to perform a complete review of their quality management system and its ability to meet the current GMP's. The FDA has added a \\"Strategic Priorities\\" initiative that can assist companies to proactively address areas of GMP concern. There is a major shift in the emphasis of the U.S. FDA cGMP compliance audits\, clinical trial expectations\, product submissions and company response requirements. In short\, all regulatory areas are under evaluation by the FDA\, and need to be revisited by a company's QA/RA and its senior management. There is \\"no business as usual\\". This change in focus has a major impact on interpretation of individual compliance objectives\, cGMP objectives\, and measurements of success. Recent negative publicity on pharmaceuticals\, devices\, as well as events in unrelated industries have put pressure on the Agency to \\"get tough on compliance / enforcement\\". This webinar will trigger such a response by an examination / review of FDA's \\"must-have\\" for corporate CGMP compliance.
Areas Covered in the Session\:
Mandated Areas for Annual Reviews
The FDA's \\"Strategic Priorities\\" for 2012 and Beyond
Tougher Regulatory Science -- What \\"Better Science\\" Really Means
Device\, Pharmaceutical and Biological Issues
General CGMP Issues -- Strengthened Compliance
FDA's Life Cycle View Requirements
Safety / Integrity of Global Supply Chain
Heightened Supplier Issues
FDA Clearance / Approval Only the Beginning -- Product \\"Lifecycles\\"
Who Will Benefit\:
Senior management in Drugs\, Devices\, Biologics\, Dietary Supplements
QA
RA
R&\;D
Engineering
Production
Operations
Consultants
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
Many top executives often feel isolated from their teams\, other leaders\, and even their families. They miss the hands-on mentoring and coaching they received on their way to becoming an executive. More and more top leaders are turning to an Executive Coach to help with their performance and development. What is an Executive Coach? How does the process work? What tools do they use?
Executive Coach and Price Associates expert Whit Mitchell gives leaders an inside perspective on Executive Coaching. From personal development to interpersonal skills to performance coaching\, Whit will discuss how Executive Coaching can fill the void top leaders often feel. This open\, transparent webinar gives you insights on how Executive Coaches are becoming a key business and personal resource for effective executives.
Date\: Thursday\, January 12\, 2012
Time\: 9\:00 am Mountain Time
What you will learn\:
* What Executive Coaching is and what it isn't
* Different Coaching Models (Life\, Interpersonal Skills\, Performance)
* Coaching Tools (Appreciative Inquiry\, Inner Circle Stakeholders\, Leadership and Team Assessments)
If you are a leader or a future leader\, this is a must-attend event for you!
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120112T180000Z DTEND;VALUE=DATE-TIME:20120112T180000Z UID:http://www.webinarcentral.net/content/statistics-quality-control-critical-decisions-risks-basics-webinar-globalcompliancepanel URL;VALUE=URI:http://www.webinarcentral.net/content/statistics-quality-control-critical-decisions-risks-basics-webinar-globalcompliancepanel SUMMARY:Statistics in Quality Control - Critical decisions-Risks & Basics - Webinar By GlobalCompliancePanel DESCRIPTION:Statistical Applications includes topics related to basic statistical applications and advanced statistical applications such as statistical process controls (SPC). Includes elements of central tendency\, dispersion\, proportions and percentages\, probability\, capability\, control limits\, specifications limits and more.
Why you should attend\: To learn of many different areas of basic and statistical process controls applications such as central tendency\, dispersion\, proportions and percentages\, graphical and normal distributions\, control limits\, specification limits\, process capability and more.
Areas Covered in the Session\:
Basic Statistics - Central tendency
Basic Statistics - Dispersion
Basic Statistics - Proportions and Percentages
Basic Statistics - Graphical displays and Normal distribution
SPC - Introduction and Data patterns
SPC - Control limits vs. Spec limits
SPC - Types of charts (variable and attribute)
SPC - Process capability
Who Will Benefit\:
Quality Managers
Quality Engineers
Small business owners
CAPA investigators
Inspectors
Technicians and Metrology/Calibration Techs
Consultants
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
There is a need to implement an adequate formal level of change control during engineering projects (referred to as an Engineering Change Control) after the approval of the equipment/systems specifications in addition to the more formal change control after the qualification of these systems.
The Engineering change control process will apply through design\, construction and qualification up to the point that the system is considered installed/operational. The new Quality Systems guideline from the FDA states that the Quality function must be involved in the review of the design and subsequent changes to the design of facilities\, equipment and systems that may impact the product quality. The question is - how much involvement is really necessary from all functional groups including the Quality group?
The course will include instructions on how to\:
Develop an Engineering Change Control system for design\, construction projects and the elements of a formal Change Control system after commercialization
Apply change control concepts while making it a practical but effective process
Determine which equipment/systems require some level of change control after the approval of specifications and which systems do not require a formal level of change control during these stages of a project
Understand the documentation requirements\, approvals and responsible resource for conducting change control at these phases and after commercialization
Why you should attend\: Most pharmaceutical companies focuses on change control management after commercialization but changes must be managed earlier during the design of facilities\, equipment and systems in addition to changes implemented during the development of the manufacturing processes. The question is\: What is the level of control required at the design/development stages? Who needs to be involved? What are the steps required for the processing of such changes and the documentation that is required to provide evidence of such controls?
Areas Covered In the Session\:
Specifications Change Control
Handling of changes to URS\, FRS\, Design Specifications
When do we implement some level of Change control
Design Change Control
Relationship between Design Qualification/Review and Change Control
Adequate/Practical Documentation Requirements for changes during design – handling of drawings
Functions to be involved and level of involvement
Change Control during Construction\, Start-Up and Commissioning
Handling of Revisions to Design\, Drawings and Specifications
Changes to Construction Reports/Documentation
Change Control Management during Qualification
Formal Change Control Management after Equipment/Systems Qualification
Standards/Regulations/Guidelines applicable to Change Control and Training Requirements
Learn the characteristics of an adequate/effective procedure and documentation form and how to deliver this message during training\:
Definitions – Like for Like\, Emergency/Unplanned vs. Normal/Planned Changes
Applications for Documentation Changes
Applications for Process Changes
Applications for Changes in equipment/systems
Who will benefit\:
Personnel in Manufacturing
Engineering
Quality
Validations
Purchasing at all levels of management
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
Why should you Attend\:
FDA Commissioner Margaret Hamburg recently announced several new enforcement initiatives. They are certain to impact your regulatory risk profile. How will you prepare for software quality\, software validation and 21 CFR part 11 planning?
Extensive use of automated manufacturing\, laboratory\, QA\, QC\, complaints\, CAPA\, Adverse Events systems puts companies at risk. FDA field staff has been trained on software validation and 21 CFR Part 11 inspection and enforcement. Many companies have fallen behind in their software validation practices. Now is the time for forward planning in this crucial area. This executive planning session discusses the key elements on which to focus. The attendee should leave this strategic planning session confident in knowing how FDA will approach software validation enforcement and how to prevent needless inspections\, as well as how to satisfy an FDA inspector.
Areas Covered in the seminar\:
Short Description\:
Explore Face Blindness\, also called Developmental Prosopagnosia\, new research to better understand its relationship with ASD\, and how to help children recognize the faces and emotions of their families\, teachers\, and friends.
Full Description\:
Why Can’t I Recognize Faces?
Researchers have discovered that 2–3% of the world’s population cannot recognize the faces of others and their own face. This “face blindness” is called Developmental Prosopagnosia and is thought to be a genetic neurobiological disorder. Recent discoveries show that Prosopagnosia is highly comorbid with Autism Spectrum Disorders (ASD) and have prompted the DSM-5 committee to consider adding problems recognizing faces to the symptoms related to ASD. Additionally\, researchers have expanded the definition of Developmental Prosopagnosia to include those who have trouble recognizing facial expressions. Those with ASD\, likewise\, often have great difficulty.
This webinar will review the current research and discuss specific ways of screening for Developmental Prosopagnosia in children with and without ASD. Empirically proven treatment methods will be discussed and specific techniques of accommodating children will be outlined.
Course Includes\:
Live Q&\;A
Presentation Handout
Post session recording access
CE Credit
What You Will Learn\:
Examine the latest research on Face Blindness\, also known as Developmental Prosopagnosia\, and how it can affect children with Autism Spectrum Disorders
Describe the symptoms and methods of screening
Discuss the neuroanatomy of Developmental Prosopagnosia
Identify methods of accommodating children with Developmental Prosopagnosia in the classroom
Outline evidence-based techniques and describe technologies that can aid in treatment
Your Presenter\:
KEVIN T. BLAKE\, PhD\, P.L.C.\, is a licensed psychologist and author with over 20 years of experience as a nationally recognized authority on learning disorders and ADHD in children\, adolescents\, and adults. This interest spurred from his own struggles overcoming a reading disorder/dyslexia and hearing impairment.
Dr. Blake serves as a member of the American Psychological Association\, International Dyslexia Association\, Children and Adults with Attention Deficit Disorders\, Learning Disabilities Association\, and the National Attention Deficit Disorder Association and was a 1991 delegate to the National Institute for Literacy’s “LEAD 2000 Congress\,” where he advised Congress on diagnostic and remediation issues.
Disclaimer\:
This event qualifies for one CE credit. Only registered attendees will have access to CE. A Cross Country Education web account is required to attend. There is no charge for a CCE web account. It is recommended that you join the meeting 15 to 20 minutes early. Speaker phone sound quality is poor and it is recommended that they not be used to listen to the event.
Technical requirements\:
To view this webinar you will need to download the WebEx Application. You will be prompted to download it when you first enter the site. To save time\, you can setup prior to the meeting by following this link\: https\://apidemoeu.webex.com/apidemoeu/meetingcenter/mcsetup.php
Who Should Attend\:
Psychologists\, Social Workers\, Licensed Professional Counselors\, Marriage and Family Therapists\, School
Psychologists\, Guidance Counselors\, Psychiatric Nurses\, Nurses\, Psychiatric Nurse Practitioners\, Pediatric
Nurse Practitioners\, Case Managers\, Clergy\, School Administrators\, Physicians\, Psychiatrists\, Mental Health
Administrators\, Special Education Teachers\, Alcoholism and Drug Abuse Counselors
During this webinar we will discuss evidence-based treatment and medications used to modify the symptoms of ADHD\, Obsessive-Compulsive Disorder\, and Tics. Similarity of symptoms\, frequency\, and their debilitating nature will also be
identified.
Full Description\:
Modify and improve symptoms of ADHD\, Obsessive-Compulsive Disorder\, and Tics with evidence-based treatment
The Triad describes a set of three disorders that have similar neuropsychological sources\: ADHD\, Obsessive-Compulsive Disorder\, and Tics. The symptoms of these disorders possess frequency\, drive\, and intensity beyond the norm. The
symptoms can be chronic and debilitating\, interfering with social\, cognitive\, and emotional development. We will discuss how symptoms can be modified and improved with evidence-based treatment. Medication to treat ADHD will also be
reviewed.
Course Includes\:
Live Q&\;A
Presentation Handout
Post session recording access
CE Credit
What You Will Learn\:
Identify the neuropsychological similarities between ADHD\, OCD\, and Tics
Discuss the research-based defining points that describe ADHD
Explain the evidence-based strategies for treating children and teens with ADHD
Recognize what psychostimulant medication is and how it is used
Distinguish between ADHD and Childhood Bipolar Disorder
Your Presenter\:
ANITA REMIG\, Ed.D. F.P.P.R.\, F.S.M.I.\, is a practicing clinical psychologist and consultant specializing in learning styles\, brain-based research and learning problem interventions. Her articles have appeared in numerous publications
including Child Study Journal\, Language and Speech and Journal of Child Psychology. Her papers have been presented to the American Educational Research Association\, American Psychological Association and the Society for Research in Child
Development. Dr. Remig's national seminars include \\"The Human Brain and Learning Styles\,\\" \\"The Human Brain and Motivation\,\\" \\"ADHD and the Brain\,\\" \\"Learning Disabilities and ADHD\: Behavioral Interventions\\" and \\"Pervasive Developmental
Disorder\: Autism\, Rett's\, CDD and Asperger's Disorder.\\" Dr. Remig is a member of the American Psychological Association and an instructor for the University of New Hampshire. She is a Fellow of the Prescribing Psychologist Register
(F.P.P.R.) and a Fellow in Serious Mental Illness (F.S.M.I.) from the Prescribing Psychologist Register. Both fellowships are awarded by the International College of Prescribing Psychologists. Dr. Remig also passed the ICCP National
Examination for Psychologists in Psychopharmacology.
Disclaimer\:
This event qualifies for one CE credit. Only registered attendees will have access to CE. A Cross Country Education web account is required to attend. There is no charge for a CCE web account. It is recommended that you join the meeting
15 to 20 minutes early. Speaker phone sound quality is poor and it is recommended that they not be used to listen to the event.
Technical requirements\:
To view this webinar you will need to download the WebEx Application. You will be prompted to download it when you first enter the site. To save time\, you can setup prior to the meeting by following this link\:
https\://apidemoeu.webex.com/apidemoeu/meetingcenter/mcsetup.php
Who Should Attend\:
Psychologists\, Psychiatrists\, Social Workers\, Counselors\, Case Managers\, Educators\, Marriage and Family Therapists\, Drug and Alcohol Abuse Counselors\, Physicians\, Nurses\, Nurse Practitioners\, Criminal Justice Personnel (Probation
Officers)\, Occupational Therapists\, Certified Occupational Therapy Assistants\, Parents
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120113T180000Z DTEND;VALUE=DATE-TIME:20120113T190000Z UID:http://www.webinarcentral.net/content/how-deliver-continuing-education-using-webinars URL;VALUE=URI:http://www.webinarcentral.net/content/how-deliver-continuing-education-using-webinars SUMMARY:How to Deliver Continuing Education Using Webinars DESCRIPTION:Don't Be Caught in the 20th Century Rut…
Many professional development leaders find themselves at a 21st century challenge\: the landscape for professional learning has changed. A new generation of members is flowing in— more diverse\, younger\, possibly self-entitled\, and very likely more tech savvy than members of the past. The traditional models of live conferences\, formal print publications\, and networking events aren't likely of interest to the new members to advance their careers.
E-learning and the use of technologies to develop a better interactive\, personalized\, and deeper experience may be a powerful remedy. Attend this live webinar to learn how to make the transition from live events to online events - painlessly.
During This Webinar You Will Learn How To\:
• Shift from a face-to-face training model to the convenience of online.
• Deliver robust e-learning and training programs to a diverse audience ~ with no travel or location costs.
• Use the latest technologies to provide CE courses without time zone or work schedule conflicts.
• Find out how one non-profit organization used online training programs to save over $85\,000 annually.
All Registrants Will Receive\:
• FREE copy of “Why Trainers are Turning to Webinars” publication that includes practical techniques to kick-start your educational programs.
• $50 ConferTel credit towards your first CLE webinar using ConferTel’s managed webinar service.
About the Presenter\:
Don Cameron\, Marketing Strategist and founder of Interactive Telesis and ConferTel\, has helped hundreds of organizations generate non-dues revenue by delivering educational webinars to their members in addition to helping businesses use an educational marketing approach to cost-effectively generate qualified sales leads.
Hospital executives have a hard job to do! In attempting to create and achieve an effective strategic plan\, there is a great need to determine specific outcomes that will be consistent with the organization's underlying mission\, broad policies\, culture and accepted industry norms….But what exactly does this mean? What are the elements that will be instantly recognizable as \\"a\\" or \\"the\\" key performance indicators (KPIs) of success across the hospital industry.
This class will highlight the results of research with several hospitals that have undertaken to develop the proper metrics\, set high goals and ensure that these goals have been met.
Areas Covered in the Session\:
Understand the need to utilize key performance indicators in daily\, biweekly\, monthly\, quarterly and annual reporting.
Recognize the key performance indicators that are being used at several other hospitals to achieve improved financial results.
Learn the best ways to present the KPIs for effective management outcomes.
Who Will Benefit\:
Hospital Chief Executive Officers
Hospital Chief Operating Officers
Hospital Chief Financial Officers
Hospital Chief Nursing Officers
Hospital Chief Information Officers
Directors of Accounting
Controllers
Finance Managers
Finance Analysts
Data Analysts
Price List\:
Live \: $195.00
Corporate live \: $695.00
Recorded \: $245.00
webinars@mentorhealth.com
http\://www.mentorhealth.com
Phone\: 800-447-9407
Fax\: 302-288-6884
Why you should attend\: Accuracy in scoring the pressure ulcer OASIS items is imperative for both payment and quality reporting. Pressure ulcers can garner considerable case mix points under the Home Health Prospective Payment System and the only potentially avoidable event reported in the Home Health Compare Outcomes is an increase in pressure ulcers. In addition there are three process items in Home Health Compare related to pressure ulcers - was an assessment completed\, was the patient at risk of developing pressure ulcers and are there interventions on the physician ordered plan of care to address pressure ulcers. It is clear from the emphasis on pressure ulcers in quality monitoring\, that the presence and action to decrease the risk of pressure ulcers is a major concern to the Centers for Medicare and Medicaid Services (CMS). Attendance at this session is important to ensure your agency's clinicians are answering these important items accurately and completely.
Areas Covered in the Session\:
Identify key components of item by item guidance for accurate responses
Describe the appropriate responses related to open and closed pressure ulcers
Identify the financial impact on both episode and non-routine supply reimbursement related to OASIS item responses
Apply the official guidance for OASIS scoring to a variety of pressure ulcer situations\, such as closed pressure ulcers\, ulcers closed with a skin graft versus other types of treatment
Describe how to score a patient who has had a muscle flap applied to a pressure ulcer that later breakdown
Identify how to obtain credit for best practice process measures related to pressure ulcers even when the patient is not determined to be at risk for pressure ulcers at the start of care
Calculate the amount of reimbursement associated with non-routine supplies based on your OASIS responses
Visualize how much revenue is impacted as a result of minimal errors in scoring OASIS
Who Will Benefit\:
Home Health Clinicians
Managers
Quality Improvement Personnel
Price List\:
Live \: $195.00
Corporate live \: $695.00
Recorded \: $245.00
webinars@mentorhealth.com
http\://www.mentorhealth.com
Phone\: 800-447-9407
Fax\: 302-288-6884
This 90 minute training course will provide your company the opportunity for comprehensive understanding of the IMPD (Investigational Medicinal Product Dossier) and the structure and content differences between a EU CTA Application and an FDA IND Application. Additionally\, this webinar covers many related processes sponsors will need to know\, as they file for\, conduct and close-out effective clinical studies in the U.S. and EU.
Why you should attend\: All sponsors\, CROs\, Sites and auditors of Clinical Research who are involved in pharmaceutical or biological development need to possess the knowledge and be efficient in completing successful applications for their studies. Knowing what is expected of you and \\"getting-it-right\\" the first time\, will allow faster development of innovative products. This translates to company and personal success and for new therapies to continue to be available to patient populations worldwide.
Areas Covered In the Session\:
US FDA and EU Agency Orientation / Structure
Start –Up and Conducting Clinical Trial Processes
Following Product Registration / Licensing Options
Company Strategy- Linking Clinical Trials &\; Marketing Authorization Applications
Balancing Strategy and Long Term Regulatory Cost &\; Maintenance
IMP Dossier &\; Comparisons of the US IND to the EU CTA Content
Scientific Advice\: Member States vs. Pre-IND Meetings with U.S. FDA
Orphan Drugs\: EU vs. US Treatment
GCP Compliance Inspections
Essentially Similar and Generic Products
Cross-Agency Interactions\: Comparing U.S. FDA and EMA
Effective Interactions with the Global Regulatory Healthcare Authorities
Helpful Websites
Who will benefit\: This Webinar will provide invaluable assistance to all personnel in the Pharmaceutical\, Biotechnology and CRO industry conducting Clinical Trials including\:
Sponsor Senior management
Project Managers
Clinical Trial Heads
Medical writers
Project Managers
CRAs and CRCs
QA / Compliance personnel
Investigators
Clinical Research Scientists
QA / QC Auditors and Staff
Consultants
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
During this webinar we will discuss evidence-based treatment and medications used to modify the symptoms of ADHD\, Obsessive-Compulsive Disorder\, and Tics. Similarity of symptoms\, frequency\, and their debilitating nature will also be
identified.
Full Description\:
Modify and improve symptoms of ADHD\, Obsessive-Compulsive Disorder\, and Tics with evidence-based treatment
The Triad describes a set of three disorders that have similar neuropsychological sources\: ADHD\, Obsessive-Compulsive Disorder\, and Tics. The symptoms of these disorders possess frequency\, drive\, and intensity beyond the norm. The
symptoms can be chronic and debilitating\, interfering with social\, cognitive\, and emotional development. We will discuss how symptoms can be modified and improved with evidence-based treatment. Medication to treat ADHD will also be
reviewed.
Course Includes\:
Live Q&\;A
Presentation Handout
Post session recording access
CE Credit
What You Will Learn\:
Identify the neuropsychological similarities between ADHD\, OCD\, and Tics
Discuss the research-based defining points that describe ADHD
Explain the evidence-based strategies for treating children and teens with ADHD
Recognize what psychostimulant medication is and how it is used
Distinguish between ADHD and Childhood Bipolar Disorder
Your Presenter\:
ANITA REMIG\, Ed.D. F.P.P.R.\, F.S.M.I.\, is a practicing clinical psychologist and consultant specializing in learning styles\, brain-based research and learning problem interventions. Her articles have appeared in numerous publications
including Child Study Journal\, Language and Speech and Journal of Child Psychology. Her papers have been presented to the American Educational Research Association\, American Psychological Association and the Society for Research in Child
Development. Dr. Remig's national seminars include \\"The Human Brain and Learning Styles\,\\" \\"The Human Brain and Motivation\,\\" \\"ADHD and the Brain\,\\" \\"Learning Disabilities and ADHD\: Behavioral Interventions\\" and \\"Pervasive Developmental
Disorder\: Autism\, Rett's\, CDD and Asperger's Disorder.\\" Dr. Remig is a member of the American Psychological Association and an instructor for the University of New Hampshire. She is a Fellow of the Prescribing Psychologist Register
(F.P.P.R.) and a Fellow in Serious Mental Illness (F.S.M.I.) from the Prescribing Psychologist Register. Both fellowships are awarded by the International College of Prescribing Psychologists. Dr. Remig also passed the ICCP National
Examination for Psychologists in Psychopharmacology.
Disclaimer\:
This event qualifies for one CE credit. Only registered attendees will have access to CE. A Cross Country Education web account is required to attend. There is no charge for a CCE web account. It is recommended that you join the meeting
15 to 20 minutes early. Speaker phone sound quality is poor and it is recommended that they not be used to listen to the event.
Technical requirements\:
To view this webinar you will need to download the WebEx Application. You will be prompted to download it when you first enter the site. To save time\, you can setup prior to the meeting by following this link\:
https\://apidemoeu.webex.com/apidemoeu/meetingcenter/mcsetup.php
Who Should Attend\:
Psychologists\, Psychiatrists\, Social Workers\, Counselors\, Case Managers\, Educators\, Marriage and Family Therapists\, Drug and Alcohol Abuse Counselors\, Physicians\, Nurses\, Nurse Practitioners\, Criminal Justice Personnel (Probation
Officers)\, Occupational Therapists\, Certified Occupational Therapy Assistants\, Parents
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120117T190000Z DTEND;VALUE=DATE-TIME:20120117T201500Z UID:http://www.webinarcentral.net/content/your-website-legal URL;VALUE=URI:http://www.webinarcentral.net/content/your-website-legal SUMMARY:Is Your Website Legal? DESCRIPTION:Title\: Is Your Website Legal?
Host\: Dr. Joseph Peck
Guest Expert\: Chip Cooper
Date\: Tuesday\, January 17\, 2012
Start Time\: 2\:00 pm Eastern (EDT)\, 1 pm Central\, 11 am pm Pacific\, 7 pm UK
Duration\: 75 minutes
Cost\: Free webinar
Is Your Website Legal?
What You Need To Know To Protect Yourself
And Your Website Business…In Every Day Language!
Including 13 Legal Gotcha’s And How To Avoid Them!
During this free webinar\, you'll learn
Why website legal compliance is now more important than ever.
Key legal trigering events you absolutely must be prepared for.
13 legal Gotcha’s that may surprise you\, and how to avoid them!
“Drive Massive Traffic To Your Business/Ministry with Facebook Fanpages”
During the webinar I am going to take you through the steps for creating a Facebook Fanpage from scratch. One that is static and one that requires the visitor to click the “like” button to get the info.
I will create two Fanpages..in real time\, one using WordPress and one without using WordPress.
I will also share how to drive massive traffic to these fanpages.
The webinar will be recorded and made available to attendees
Attend the webinar to get your questions answered in real time.
Please note\: If you have a webcam and/or microphone you can interact with the presentor and ask questions. You can also ask questions via text message during the webinar. Six people can interact at the same time.
Seminar Dates and times.. ..Eastern Time Zone
Saturday\, January 14\, 3\:30 PM registration form\: http\://www.anymeeting.com/PIID=EB52D682804A
Sunday\, January 15\, 3\:00 PM registration form \: http\://www.anymeeting.com/PIID=EB52D6828249
Tuesday\, January 17\, 7\:00 PM registration form\: http\://www.anymeeting.com/PIID=EB53DA81894E
Registration is required.
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120118T170000Z DTEND;VALUE=DATE-TIME:20120118T174500Z UID:http://www.webinarcentral.net/content/strategic-service-desk-future-support URL;VALUE=URI:http://www.webinarcentral.net/content/strategic-service-desk-future-support SUMMARY:The Strategic Service Desk & the Future of Support DESCRIPTION:Service Desk Management Online SummitAbout this summitAs an IT service manager\, maintaining a highly successful service desk requires being able to efficiently handle incoming requests and incidents\, understanding and knowing your customers and effectively managing change. Attend this summit to hear the latest best practices from industry experts\, analysts and end-users on how to manage your service desk to improve productivity and increase customer satisfaction. An emphasis will be placed on the modern service desk\, discussing the impact of social media\, ITIL 2011 and why you need a customer-savvy approach to service management.For more information and to register\:
\\" target=\\"_blank\\">http\://www.brighttalk.com/r/d7h
Charles Araujo of the IT Transformation Institute presents\:
The Strategic Service Desk &\; the Future of Support
Wednesday\, January 18\, 2012 | 9\:00am PST/12\:00pm EST | 45 min
What will the future of support look like? We are entering a time of rapid and fundamental change in the world of IT. With the disruptors of cloud computing\, mobility and social business going mainstream\, the fundamental relationship between IT and its customers is changing. How will this impact the Service Desk and what must support organizations and professionals be doing now to prepare for this future?Based on an upcoming HDI article and a series of blog posts\, Charles Araujo and Shane Carlson will explore this future\, examining how support will become social and why service desks will begin to look more like an Apple store. This interactive presentation will challenge current ideas of how support should be delivered and describe what it will take for Service Desks to become truly strategic and remain relevant in this upcoming era of IT.For more information and to register\:
\\" target=\\"_blank\\">http\://www.brighttalk.com/r/d7h
If you're turning 65 and about to navigate Medicare\, join us for this webinar to learn about the costs\, dates\, and advantage &\; supplement plans available to you. Space is limited so register today.
About the Company\:
iQuote helps you make sense of the many choices available to you when evaluating Medicare Advantage plans and Medicare Supplemental Insurance options. iQuote works with over 24 companies nationwide.
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120118T200000Z DTEND;VALUE=DATE-TIME:20120118T200000Z UID:http://www.webinarcentral.net/content/integrating-art-therapy-your-professional-practice URL;VALUE=URI:http://www.webinarcentral.net/content/integrating-art-therapy-your-professional-practice SUMMARY:Integrating Art Therapy into your Professional Practice DESCRIPTION:Short Description\:
This one-hour webinar provides attendees with a definition of art therapy\, its benefits\, &\; how it differs from verbal therapy. Case studies will be presented to assist attendees in identifying indicators &\; key images in their clients' art.
Full Description\:
Identify expressions of mood through your clients' drawings and paintings
This webinar program provides definitions of what Art Therapy is and how it differs from verbal therapy. The role of art-making in diagnosis and treatment is addressed through assessment by examining age-appropriate drawing skills and the symbolism of images that have personal meaning to our clients. In addition\, this course examines art-making as personal growth and its therapeutic benefits. The attendees will learn specific indicators to look for in their clients' art work and how to identify key images through the presentation of several case studies. Through these case studies the participants will identify how clients can express their mood through drawing and painting. Psychological and behavioral problems\, such as regression and impairments\, will be identified through the symbolism in clients' art work.
Course Includes\:
Live Q&\;A
Presentation Handout
Post session recording access
CE Credit
What You Will Learn\:
Discover a new method of communicating with clients
Examine effective Art Therapy techniques
Understand the therapeutic power that art provides
Acquire skills for assessing the client's stress level
Discuss current research as it relates to Art Therapy and its effectiveness with clients
Your Presenter\:
PAMELA M. HAYES\, MFT\, LMHC\, ATR-BC\, is an artist and a registered and board certified Art Therapist. She is licensed as a Marriage and Family Therapist and Mental Health Counselor and is currently in private practice in Los Angeles\,
California. Ms. Hayes developed the art therapy program at the Rhode Island School of Design–Continuing Education. For the past 15 years\, Ms. Hayes has worked in numerous psychiatric settings with a variety of clients. Currently\, her focus includes families\, couples\, adults and children struggling with mood and anxiety disorders\, addiction\, eating disorders\, abuse and grief-related issues. Ms. Hayes has an undergraduate degree in Fine Arts from Parsons School of Design in New York City and a graduate degree in Marriage and Family Therapy and Art Therapy from Notre Dame de Namur University in Belmont\, California. For more information about Ms. Hayes\, please visit her website at\: www.hayesarttherapy.com.
Disclaimer\:
This event qualifies for one CE credit. Only registered attendees will have access to CE. A Cross Country Education web account is required to attend. There is no charge for a CCE web account. It is recommended that you join the meeting 15 to 20 minutes early. Speaker phone sound quality is poor and it is recommended that they not be used to listen to the event.
Technical requirements\:
To view this webinar you will need to download the WebEx Application. You will be prompted to download it when you first enter the site. To save time\, you can setup prior to the meeting by following this link\:
https\://apidemoeu.webex.com/apidemoeu/meetingcenter/mcsetup.php
Who Should Attend\:
Marriage and Family Therapists\, Licensed Professional Counselors\, Social Workers\, Psychiatric Nurses\, Drug and Alcohol Abuse Counselors\, Pediatricians\, Physicians\, Art Therapists\, Pastoral Counselors\, Guidance Counselors\, Youth Pastors\,
Youth Counselors\, Educators
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120119T073000Z DTEND;VALUE=DATE-TIME:20120119T190100Z UID:http://www.webinarcentral.net/content/top-10-ways-feed-your-content-beast URL;VALUE=URI:http://www.webinarcentral.net/content/top-10-ways-feed-your-content-beast SUMMARY:Top 10 Ways to Feed Your Content Beast DESCRIPTION:Join HiveFire\, Hubspot and the AMA for a free webinar discussing how content marketing can drive solid revenue growth.
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120119T180000Z DTEND;VALUE=DATE-TIME:20120119T180000Z UID:http://www.webinarcentral.net/content/risk-management-iec-60601-1-third-edition-webinar-globalcompliancepanel URL;VALUE=URI:http://www.webinarcentral.net/content/risk-management-iec-60601-1-third-edition-webinar-globalcompliancepanel SUMMARY:Risk Management in IEC 60601-1 Third Edition - Webinar By GlobalCompliancePanel DESCRIPTION:IEC 60601-1 Third Edition was released in late 2005. It is a new philosophy in standards for medical electrical devices to accommodate rapid advances in technology.
This new philosophy has been difficult for test houses and compliance bodies to absorb and develop test strategies. Currently\, the EU and Canada have announced May 31-June 1\, 2012 as the date when the Second Edition will be withdrawn. Devices that will be released after that date must meet the requirements of the Third Edition. Manufacturers with products under development must start now to develop compliance strategies. The first step will be understanding the requirements of the new standard.
Areas Covered in the Session\:
ISO 14971 compliance is a requirement of IEC 60601-1
The new standard uses risk management throughout
The new standard is less prescriptive in many areas
The new standard requires that all applicable collateral and particular standards must be used for compliance
Current activities leading to full implementation of the standard
Available documents to guide implementation of the Third Edition
Who Will Benefit\:
Design Engineers
Quality Engineers and Managers
Compliance Engineers
Engineering Managers
Project Managers
Verification and Validation Engineers and Mangers
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
This webinar will discuss the new draft guidance document from the FDA\: \\"510(k) Device Modifications\: Deciding When to Submit a 510(k) for a Change to an Existing Device\\"\, dated July 27\, 2011.
It will examine the broad range of issues to be considered by a company when reviewing
1) A series of minor changes or
2) One major change to an existing product having an existing 510(k)\, for the need for a new 510(k).
Such a review takes on added urgency as a result of the stated intent of the Agency to get tougher across the board in its expectations for the medical industry and what it (the FDA and industry) need to do to \\"toughen\\" the 510(k) process. A review of recent information from the Agency\, including last summer's Working Group findings on the 510(k)\, Vol. I\, as well as other goals of the Agency that have already been translated into action in the past year will provide direction in areas of concern and what to expect in the future. This will be performed by a review of FDA-stated areas of required review and a suggested matrix format . Anticipation and addressing such on-going product modifications / changes proactively will further prove a company is \\"in control\\"\, and assist documenting the 510(k) submission (or 'not') rationale.
Why you should attend\: The FDA expects companies to perform meaningful\, results driven 510(k) / change analysis activities. The company is held fully responsible for deciding when a new 510(k) filing is warranted. Now a new draft guidance document from the FDA is designed to add more consistency to this process\: \\"510(k) Device Modifications\: Deciding When to Submit a 510(k) for a Change to an Existing Device\\"\, dated July 27\, 2011. In addition\, growing high-profile field problems indicate that change control and its effect on regulatory review activities are not yet fully utilizing the power of current risk management tools\, which must be a part of such an analysis. A growing push by the Agency to strengthen the 510(k) process\, and review existing devices with above normal adverse events are additional results. Current methods are claimed to not be providing the product safety or efficacy seemingly promised. For most companies\, the recommended fixes and incorporation of current Agency thinking are not rocket-science\, but require the implementation of formal methods with documented\, and defensible\, rationale.
Areas Covered in the Session\:
FDA Device Clearance / Changes in Direction
The New Draft Guidance on Product Changes and Filing a New 510(k)
The New Guidance on Manufacturing\, Labeling\, Tech/Performance and/or+B41 Materials Changes
Tracking / Evaluating Changes and the \\"Tipping Point\\"
Expanding FDA's K97-1 and \\"Decision Tree\\" Model / Matrix
Resolving a \\"Wrong\\" Decision
Who Will Benefit\:
Senior management in Devices and Combo Products
QA
RA
R&\;D
Engineering
Production
Operations
Consultants
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
During this webinar we will examine the DSM-IV diagnostic symptoms of Childhood Bipolar Disorder and review innovative research. Executive deficits and behavioral changes signaling the onset of the disorder will also be discussed.
Full Description\:
Diagnosing Childhood Bipolar Disorder and Treatment Strategies
During this one-hour webinar\, we will outline the DSM-IV diagnostic symptoms of bipolar disorder and review innovative research on bipolar disorder contrasted with a new DSM-IV diagnosis. Research on the sequelae of bipolar disorder\, including executive deficits\, will be described as well as the prodromal conditions and behavioral changes that signal the onset of childhood bipolar disorder. A probability nomogram\, a novel decision tool which improves the interpretation of family history and test data by diagnosing clinicians\, will be presented and discussed. Strategies by Dr. Miklowitz will be offered to support clinical and educational treatment options.
Course Includes\:
Live Q&\;A
Presentation Handout
Post session recording access
CE Credit
What You Will Learn\:
List the criteria for Bipolar I and Bipolar II from the DSM-IV
Discuss the work of Dr. Ellen Leibenluft related to Childhood Bipolar Disorder
Define the role of episodicity in Childhood Bipolar Disorder
Recognize the effects of Childhood Bipolar Disorder on the developing brain
Identify the prodromes for Childhood Bipolar Disorder
Your Presenter\:
ANITA REMIG\, Ed.D. F.P.P.R.\, F.S.M.I.\, is a practicing clinical psychologist and consultant specializing in learning styles\, brain-based research and learning problem interventions. Her articles have appeared in numerous publications including Child Study Journal\, Language and Speech and Journal of Child Psychology. Her papers have been presented to the American Educational Research Association\, American Psychological Association and the Society for Research in Child Development. Dr. Remig's national seminars include \\"The Human Brain and Learning Styles\,\\" \\"The Human Brain and Motivation\,\\" \\"ADHD and the Brain\,\\" \\"Learning Disabilities and ADHD\: Behavioral Interventions\\" and \\"Pervasive Developmental Disorder\: Autism\, Rett's\, CDD and Asperger's Disorder.\\" Dr. Remig is a member of the American Psychological Association and an instructor for the University of New Hampshire. She is a Fellow of the Prescribing Psychologist Register (F.P.P.R.) and a Fellow in Serious Mental Illness (F.S.M.I.) from the Prescribing Psychologist Register. Both fellowships are awarded by the International College of Prescribing Psychologists. Dr. Remig also passed the ICCP National Examination for Psychologists in Psychopharmacology.
Disclaimer\:
This event qualifies for one CE credit. Only registered attendees will have access to CE. A Cross Country Education web account is required to attend. There is no charge for a CCE web account. It is recommended that you join the meeting 15 to 20 minutes early. Speaker phone sound quality is poor and it is recommended that they not be used to listen to the event.
Technical requirements\:
To view this webinar you will need to download the WebEx Application. You will be prompted to download it when you first enter the site. To save time\, you can setup prior to the meeting by following this link\:
https\://apidemoeu.webex.com/apidemoeu/meetingcenter/mcsetup.php
Who Should Attend\:
Psychologists\, Psychiatrists\, Social Workers\, Counselors\, Case Managers\, Educators\, Marriage and Family Therapists\, Drug and Alcohol Abuse Counselors\, Physicians\, Nurses\, Nurse Practitioners\, Criminal Justice Personnel (Probation Officers)\, Occupational Therapists\, Certified Occupational Therapy Assistants\, Parents
The psychological evaluation is a critical\, often mandatory step. This course helps mental health professionals become more adept when assessing and consulting bariatric surgery candidates.
Full Description\:
Is my patient prepared for weight loss surgery?
Bariatric surgery as a means of weight loss has become increasingly popular over the past decade\, so much so that it is now deemed as a medical necessity in most cases of morbid obesity. The FDA is now making the recommendation that
weight loss surgery be available to those with a lower BMI (BMI>\;30). With a potential growing number of these surgeries\, there is a significant co-morbidity of psychological factors that need to be assessed and identified before patients
can be approved for surgery.
The psychological evaluation of the bariatric surgical candidate is considered to be a most critical and necessary step in the pre-surgical process. Mental health professionals are being sought with increased demand\, not only in the
evaluation of surgical candidates\, but also to treat patients who are not yet deemed ready for surgery. This course is designed to review the process of gastric bypass procedures\, and help mental health professionals at all levels become
more adept in providing services of assessment and consultation.
Course Includes\:
Live Q&\;A
Presentation Handout
Post session recording access
CE Credit
What You Will Learn\:
Evaluate candidates for bariatric surgery and psychological contraindications
Determine which populations need additional therapeutic work prior to the surgical process
Gain a better understanding of the emotional and psychological risks and benefits of bariatric surgery for patients with morbid obesity
Your Presenter\:
MICHAEL WETTER\, PsyD\, DAPA\, is a clinical psychologist with 18 years of experience and serves as the Psychological Services Coordinator for the Center for Weight Loss at Cedars-Sinai Medical Center in Los Angeles where he performs pre-
surgical evaluations and assessment of patients undergoing bariatric surgery. He earned a master's degree in Counseling Psychology from Northwestern University\, a Doctorate in Clinical Psychology from Pepperdine University\, and completed
a formal post-doctoral fellowship at the Kaiser Permanente Medical Group. Dr. Wetter has also acted as a consultant for publications such as the Washington Post\, the Boston Globe\, the Atlanta Journal-Constitution\, Men's Health magazine\,
Forbes magazine\, Prevention magazine\, and Redbook magazine.
In addition\, Dr. Wetter is a Diplomate of the American Psychotherapy Association\, has served as an adjunct professor at numerous universities\, and is a guest lecturer nationwide training psychologists and other mental health
professionals.
Disclaimer\:
This event qualifies for one CE credit. Only registered attendees will have access to CE. A Cross Country Education web account is required to attend. There is no charge for a CCE web account. It is recommended that you join the meeting
15 to 20 minutes early. Speaker phone sound quality is poor and it is recommended that they not be used to listen to the event.
Technical requirements\:
To view this webinar you will need to download the WebEx Application. You will be prompted to download it when you first enter the site. To save time\, you can setup prior to the meeting by following this link\:
https\://apidemoeu.webex.com/apidemoeu/meetingcenter/mcsetup.php
Who Should Attend\:
Psychologists\, Licensed Professional Counselors\, Psychiatric Nurse Practitioners\, Psychiatric Nurse\, Mental Health Nurses\, Social Workers\, Marriage and Family Therapists\, Gastroenterology Nurses\, Physician Assistants\,Physicians\,
Psychiatrists\, Primary Care Nurses
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120119T180000Z DTEND;VALUE=DATE-TIME:20120119T180000Z UID:http://www.webinarcentral.net/content/top-10-ways-feed-your-content-beast-0 URL;VALUE=URI:http://www.webinarcentral.net/content/top-10-ways-feed-your-content-beast-0 SUMMARY:Top 10 Ways to Feed Your Content Beast DESCRIPTION:Join HiveFire\, Hubspot and the AMA for a free webinar discussing how content marketing can drive solid revenue growth.
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120120T180000Z DTEND;VALUE=DATE-TIME:20120120T190000Z UID:http://www.webinarcentral.net/content/3-ways-keep-sales-momentum-going URL;VALUE=URI:http://www.webinarcentral.net/content/3-ways-keep-sales-momentum-going SUMMARY:3 Ways to Keep Sales Momentum Going DESCRIPTION:In today’s crazy-busy world\, capturing and keeping your prospect's attention requires Herculean efforts. One day a prospect states their desire to change\, the next day they default to the status quo. If you’re in sales\, you’re constantly searching for articles\, webinars &\; videos etc.\, that you can use to keep the sales momentum going.
Join Jill Konrath\, bestselling author of SNAP Selling &\; Selling to Big Companies\, on Jan. 20\, 2012 at 1\:00PM EST to learn how to use content at each stage of your prospect’s decision-making process to increase their interest in and commitment to change.
During this 39-minute session\, you'll discover how to\:
*Get noticed by more hot prospects by creating content that identifies your company as an industry thought-leader.
*Quickly advance the sales process by creating campaigns that pique your prospect’s curiosity and engages them in provocative conversations.
*Build rapport by repurposing existing content to nurture prospects and customers over time.
Stop your opportunities from getting delayed\, derailed\, dismissed\, or deleted. Register today to learn how to keep your prospects in the game!
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120121T020400Z DTEND;VALUE=DATE-TIME:20120121T020400Z UID:http://www.webinarcentral.net/content/get-agile-2012 URL;VALUE=URI:http://www.webinarcentral.net/content/get-agile-2012 SUMMARY:Get Agile in 2012 DESCRIPTION:Tech Webinar - Get Agile in 2012
You are invited for a Corp-Corp Tech Webinar on Friday\, January 20th\, at 4.00 pm EST\, about \\"Get Agile in 2012\\".
In this 60-minute webinar session\, following topics will be covered\:
Ways to identify what kept you from achieving Agility in 2012
How to celebrate the progress you have made
Tips for launching into 2012 with Agility
Strategies for keeping your move to Agility in focus
Action steps you can take to maintain momentum and motivation
To register\, please use the below link
http\://www.corp-corp.com/blog/get-agile-in-2012/?aid=cc
There will be a Q&\;A session at the end of webinar.
Register now and join with us.
Join this webinar on Monday\, 23rd January\, 2012
Time\: 4\:00 pm – 5\:00 pm IST
Register Here\: https\://www1.gotomeeting.com/register/355900928
As part of BMC’s Business Services Management (BSM) strategy\, the Release
Management module that is included with BMC Remedy Change Management includes built-in ITIL V3 best practices to track and manage change and deployment activities. The goal of Release Management is provide enhanced out-of-the-box support for managing standard release activities from request to planning and design\, build\, test\, deployment and acceptance.
AGENDA
About Release Management
Release Request Lifecycle
Release Management form views
Roles in Release Management
Approvals involved in release requests
Release Management Tasks
Vyom Labs Pvt. Ltd.
IT Infrastructure Management | Solutions &\; Services
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120124T160000Z DTEND;VALUE=DATE-TIME:20120124T160000Z UID:http://www.webinarcentral.net/content/zero-sum-marketing-creating-marketing-plan-ground URL;VALUE=URI:http://www.webinarcentral.net/content/zero-sum-marketing-creating-marketing-plan-ground SUMMARY:Zero-Sum Marketing\: Creating a Marketing Plan from the Ground Up DESCRIPTION:In Zero Sum Marketing\, Brand Strategist and Price Associates expert Justin Foster re-wires traditional thinking on marketing plans\, discusses the critical elements of an effective plan\, and provides a template for creating your own plan.
In this webinar\, you will learn how to\:
• Establish Desired Outcomes
• Determine your Message
• Define your Audience
• Select the Right Tools
• Measure Results and Adjust your Plan
As with all of Justin's presentations\, you will find this one to be thought-provoking\, useful\, and fun. This is an \\"open\\" webinar\, so feel free to invite your network\, clients\, friends\, etc. to participate.
Date\: January 24\, Tuesday
Time\: 9\:00 am
Presenter\:
Justin Foster is a Brand Strategist\, published author\, professional speaker and workshop facilitator. He is the author of “Oatmeal v Bacon\: How to Differentiate in a Generic World”. Over the past 20 plus years\, Justin has worked in sales and marketing for small businesses and large corporations\, co-founded two marketing/branding firms\, and conducted over 300 workshops and seminars.
Overview \: This presentation will provide attendees with an introduction to some of the many new regulations relating to employee benefits\, with a focus on regulations that have been issued in the past year or so.
Most of the new regulations relate to the Patient Protection and Affordable Care Act (PPACA\, also known as health care reform). Other regulations that will be summarized include the ADA (Americans with Disabilities) Amendments Act (ADAAA) and Health Insurance Portability and Accountability Act (HIPAA).
Regulations to be addressed include\:
On November 17\, 2010\, the Internal Revenue Service (IRS)\, the Employee Benefits Security Administration (EBSA) and the Office of Consumer Information and Insurance Oversight (OCIIO) jointly issued an amendment to the interim final rules published on June 17\, 2010 regarding permissible changes health plans can make in order to maintain their status as a \\"grandfathered plan\\".
On November 22\, 2010\, the Department of Health and Human Services (HHS) issued interim final regulations implementing the “medical loss ratio” (MLR) provisions of PPACA.
On February 9\, 2011\, HHS announced a proposed rule extending some of the patient protections of PPACA to student health insurance plans.
On March 25\, 2011\, the Equal Employment Opportunity Commission (EEOC) published final regulations implementing the ADAAA. The ADAAA greatly expands the number of people protected by the ADA.
On May 19\, 2011\, HHS issued a final regulation intended to ensure that large health insurance premium increases will be thoroughly reviewed and consumers will have access to clear information about those increases.
On May 31\, 2011\, the Office for Civil Rights (OCR) within HHS published proposed changes to the Privacy Rule under HIPAA pursuant to the Health Information Technology for Economic and Clinical Health (HITECH) Act.
On June 24\, 2011\, the IRS\, EBSA and HHS issued interim final rules and model notices on internal claims and appeals and external review processes. These rules interpret PPACA’s requirement that plans provide notices about appeal rights in a culturally and linguistically appropriate manner.
On June 30\, 2011\, HHS published interim final rules regarding electronic data interchange (EDI). The rules require compliance by health plans\, health care clearinghouses and certain health care providers by January 1\, 2013.
On July 11\, 2011\, HHS proposed regulations to assist states in building Affordable Insurance Exchanges\, state-based competitive marketplaces where individuals and small businesses will be able to purchase private health insurance.
On August 12\, 2011\, HHS along with the Department of the Treasury released three more proposed rules related to developing Affordable Insurance Exchanges (Exchanges).
On August 17\, 2011\, the Departments of Labor\, HHS and Treasury proposed new rules under PPACA that are intended to enable consumers to understand their health coverage more easily and determine the best health insurance options for themselves and their families. PPACA requires all health insurers and group health plans to provide enrollees an accurate Summary of Benefits and Coverage (SBC).
On October 20\, 2011\, HHS announced final rules regarding Accountable Care Organizations (ACOs). These regulations launch the Medicare Shared Savings Program and the Advance Payment model.
Why you should attend\: The employee benefits field is constantly changing. Employee benefits professionals need to keep up with the latest developments\, including regulatory changes. Compliance is not optional and what you don't know can hurt you!
Some of the new regulations apply to or will affect all or virtually all employers. Do you know the latest rules governing grandfathered plans? What about the new requirements regarding claims and appeals? Do you know what an SBC is? It is a Summary of Benefits and Coverage-you will have to provide one if you sponsor a health plan. ACOs may revolutionize health care-do you know what they are? They are Accountable Care Organizations. Similarly\, health insurance exchanges will impact all plans\, even those that do not participate.
In addition to regulations under the Patient Protection and Affordable Care Act (PPACA\, also known as health care reform) there are new regulations under the ADA (Americans with Disabilities Act) Amendments Act and new privacy regulations under the Health Insurance Portability and Accountability Act (HIPAA) that will have broad applicability.
Some of the regulations issued in the past year or so are very specialized and only apply to certain types of plans\, like student health plans. Others\, like the medical loss ratio regulations or the rules on rate increases apply only to insurers\, but not self-funded plans. Some regulations\, like those regarding electronic data interchange\, apply more generally\, but typically employers rely on their insurers and administrators to comply. Of course\, if you fall into one of these categories\, you need to know about the rules.
Areas Covered in the Session\:
Health Care Reform
Grandfathered Plans
Medical Loss Ratios
Student Health Insurance Plans
Premium Increases
Claims and Appeals
Exchanges
Summary of Benefits and Coverage
Accountable Care Organizations
HIPAA
Privacy
Electronic Data Interchange
ADA Amendments Act
Who Will Benefit\:
Vice President of Human Resources
Director of Compensation and Benefits
Benefit Manager
Benefit Specialist
Insurance Agent
Insurance Broker
Employee Benefits Consultant
Group Insurance Representative
Strategic portfolio planning is crucial for developing long-term company strategy.
The goal is to meet strategic objectives selecting the \\"best\\" portfolio of internal and external drug development programs for funding and balance company resources including money\, manpower and manufacturing capacity. Projects could be interdependent\, have multiple development scenarios\, and are subject to multiple business rules specific for the company environment. Value of each project depends on multiple factors\, and could be quantitative or qualitative.
Strategic portfolio planning should be based on robust data collection processes. During the webinar we will discuss what data we need\, and how to derive them.
Without specific tools\, portfolio planning process could be extremely slow and cumbersome process. However\, many of tools have limited capabilities. We believe that most comprehensive solution could be based on optimization modeling providing flexible and powerful portfolio analysis. During the webinar we will discuss intuitive examples and case studies\, illustrating benefits of optimization approach for portfolio planning.
Why you should attend\: Neglecting optimization in portfolio planning could lead to ineffective planning solutions and missing opportunities. Without proper tools any feasible portfolio planning solution looks good\; However\, it might be far from optimal by up to 50%. Suboptimal resource allocation as a part of portfolio planning solution\, and misalignment between strategy and available resources may cause uncertainty in decision making process. Some companies use \\"simple\\" portfolio planning tools based on ranking projects. Those tools may generate ineffective solutions doubting executive management.
Areas Covered in the Session\:
Overview of strategic portfolio planning for biopharmaceutical companies
Introduction to portfolio optimization
Overview of portfolio optimization model
Data collection and analysis
Case studies illustrating effectiveness of proposed approach
Optimal portfolio selection
Forced projects prioritization
Contingency planning due to a clinical trial failure
Resource bottleneck analysis
Portfolio planning with multiple goals
Who Will Benefit\:
Portfolio planning\, VP\, Director\, manager
Financial analysts\, Directors\, VPs\, managers
Clinical Operations\, VP\, Director\, planner\, manager
Business Development\, VP\, Director\, analyst\, manager
Discovery portfolio\, VP\, Director\, manager
Manufacturing\, VP\, Director\, manager
Marketing\, VP\, Director Manager
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
Overview \: This webinar will highlight the basic areas which need to be addressed regarding the safety and security of your employees and your company. It will also cover topics for consideration in your Employee Policy Manuals\, Safety Manuals\, Procedural Manuals and Crisis Manual.
Although you will need to customize the Plan for your own company and industry\, this webinar can serve as a check point to review your current practices as well as help you prepare an outline to formalize\, consolidate and communicate your policies and procedures in a crisis manual.
Why you should attend\: Often the responsibilities at the time of crisis fall on several key managers in the company. This webinar explains the role of Human Resources or whoever has the job of defining responsibilities and coordinating the major aspects of keeping the employees and company safe and functioning at times of crisis. A well-designed and coordinated Plan can prevent situations from being more harmful\, save lives as well as saving much money by minimizing liability and keeping the business operating smoothly.
Areas Covered in the Session\:
Selecting your crisis team\; defining and assigning responsibilities
Essential policies and procedures to address emergencies
Employee training programs
Emergency call lists
Emergency medical services
Reporting accidents and incidents
Evacuation plans
Disaster recovery plans and backup systems
Interruptions in customer service and business
Communications and media coverage
Briefing and Debriefing
Violence or threats in the workplace
Natural disasters and severe weather policies
Emergency preparedness for individuals with disabilities
Payroll
Employee assistance programs
Complying with applicable laws
Who Will Benefit\:
Anyone responsible for the safety and security of employees and the protection
Human Resources
Security
IT and Finance Directors
Legal Counsel
This webinar will describe the regulatory and business requirements for Excel spreadsheets\, using examples from FDA recommendations. It will then cover the design and installation of those Excel Spreadsheets\, to ensure the integrity of the data\, and will discuss how to ensure 21 CFR 11 compliance during the development\, installation and maintenance of a spreadsheet application.
Why should you attend\: Spreadsheet Applications such as MS Excel are frequently used in 21 CFR 11 compliant environments\, but they were not specifically designed for regulated environments and their development is not optimized for 21 CFR 11 compliance. However\, the FDA expects that spreadsheets be compliant and lack of compliance can result in a warning letter. Consequently\, validation of Excel Spreadsheet Applications is required as part of a 21 CFR 11 compliant environment.
Areas Covered in the Session\:
Requirements for Excel Spreadsheets
FDA Part 11 Validation Guidance
Compliance Problems with Spreadsheets
Design Specifications for 21 CFR 11 compliance
How does the FDA Design and Use spreadsheets
Documentation for Part 11
Future Trends in 21 CFR 11 compliance for Excel Spreadsheets
Who Will Benefit\:
Quality Managers
Quality Engineers
Small business owners
Internal and external auditors
Management Reps
FDA inspectors
Consultants
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
This webinar will develop your vision to see and work on Oracle Purchasing Application. At the same time it will make you familiar with process flows\, corporate and career benefits of Oracle Purchasing
The below given topics will be covered within this exciting webinar\:
- Introduction to Oracle Purchasing
- Procure to Pay Lifecycle in Enterprise Structure
- Supplier Management
- Flow of RFQ &\; Quotation throughout the process
- Requisition and purchase order management
- Receiving and accounting flow in procure to pay
- Basic setup sequence in Oracle Purchasing
- Corporate and Career benefits
- FAQs
- And much more!
This webinar is registration-only and is intended for current and prospective clients of Oracle R12 Purchasing Application. We reserve the right to approve or deny registrations accordingly.
Free Registration\: https\://www1.gotomeeting.com/register/225415192
Target Audience\: Functional Implementers\, Oracle Database\, End Users
Read More\: http\://www.iwarelogic.com/resources/services-resources/webinars/visionar...
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120125T150000Z DTEND;VALUE=DATE-TIME:20120125T150000Z UID:http://www.webinarcentral.net/content/how-migrate-drug-safety-and-pharmacovigilance-data-cost-effectively-and-minimum-risk URL;VALUE=URI:http://www.webinarcentral.net/content/how-migrate-drug-safety-and-pharmacovigilance-data-cost-effectively-and-minimum-risk SUMMARY:How to Migrate Drug Safety and Pharmacovigilance Data Cost-Effectively and with Minimum Risk DESCRIPTION:With the advancement of technology and the high cost of maintaining legacy safety and pharmacovigilance systems\, organizations are forced to migrate to the latest technologies such as Argus Safety\, that offer the most beneficial and relevant features.
Compliance and business risks associated with safety data and the real potential for migration error (mapping errors\, different dictionary maintenance practices\, and MedDRA/WHO coding inconsistencies) introduces significant challenges\, or an opportunity to excel.
BioPharm Systems and Valiance Partners\, together\, offer a comprehensive solution that can tackle even the most complex migrations and implementations. With a cost-effective overall strategy that incorporates proven technology and business processes\, your organization can ensure a successful migration and implementation while identifying and mitigating risk.
Please join BioPharm Systems’ Dr. Rodney Lemery and Valiance Partners’ Richard Higger for a free one-hour webinar that will explore\:
• The types of risks and challenges associated with safety data system migrations
• How to successfully approach a safety and pharmacovigilance system migration and implementation project
• The benefits of pre-configured migration software and automated migration testing (100% testing)
• Examples of past migration and implementation projects
• Your own migration questions and challenges
Wednesday\, January 25\, 2012 @\:
7\:00 a.m. US Pacific time
8\:00 a.m. US Mountain time
9\:00 a.m. US Central time
10\:00 a.m. US Eastern time
15\:00 UK time
16\:00 Central European time
Webinar date\: 25th January 2012
Webinar time\: 11 AM US EST/ 4 PM GMT/ 9.30 PM India
Speakers\:
Anga Sanders\, MLA\, SPHR\, CEO at Global HR Solutions LLC
Arvinder S Dhesi\, Group Talent Director at Towers Watson
Mitch Byers\, SPHR\,Senior Human Resources Director at JDC Healthcare Management LLC \,Dallas
Lee Cooper\, Editor at www.intelligentlyemotional.com
Agenda-Continuous Feedback Vs Performance Appraisal
Today the world of business is going through challenging times. Hiring the minds and skills of people is no longer sufficient. We need to inspire people and invoke their passion. This requires continuous dialogue and feedback between people and their organization.
- What is Continuous Feedback?
- With business leaders and managers busy with their day to day goals\, how can we help them take an active role in nurturing and growing the talent within their respective teams?
- Can an Organization wide common template be used for Continuous Feedback.
- How can Continuous Feedback help in aligning the Organization’s goals with the individual interests and aspirations?
- How can an organization move up the value chain from a culture of \\"Yearly Performance Appraisals driven by HR\\"\, to a culture of \\"Continuous Feedback\, Talent Nurturing\, Growth and Development\\"?
For Registration\: http\://www.synergita.com/webinar.html
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120125T160000Z DTEND;VALUE=DATE-TIME:20120125T180000Z UID:http://www.webinarcentral.net/content/end-user-experience-30-min-webinar-wed-jan-25th-11-am-et-or-1-pm-et URL;VALUE=URI:http://www.webinarcentral.net/content/end-user-experience-30-min-webinar-wed-jan-25th-11-am-et-or-1-pm-et SUMMARY:End User Experience\, 30-Min Webinar Wed. Jan. 25th ~ 11 AM ET or 1 PM ET DESCRIPTION:Banish Poor Application Performance\:
Eliminate Business Disruptions\, Increase End User Productivity
Live 30-Minute Webinar\, Bonus VDI Whitepaper
Are you ready to gain the proactive ability to rapidly respond to end user problems (before they call the help desk)? Then you won’t want to miss a special event that will show you the latest innovation in end user monitoring. Register today for a 30-minute webinar hosted by Aternity – the company that redefines real end user experience management. Aternity will showcase its latest release – Version 5.0 of its Frontline Performance Intelligence (FPI) Platform – during the webinar.
About this 30-Minute Webinar
Join Aternity for a live 30-minute webinar and see how Aternity’s Frontline Performance Intelligence (FPI) Platform v5.0 uniquely monitors the three primary components that dynamically interact at all times to define and impact an end user’s experience as an IT consumer\: Application Performance\, Device Performance\, and User Productivity. Frontline Performance Intelligence is the result of the real-time aggregation\, analysis and correlation of all these metrics\, ultimately closing the visibility gap from the Desktop Vantage Point.
As a special bonus\, all webinar registrants will receive a copy of Aternity's newest whitepaper on Monitoring End User Experience in VDI Environments.
Join Us
Select which session you would like to join!
11 AM ET / 8 AM PT\: Register Now!
1 PM ET / 10 AM PT\: Register Now!
What Attendees Will Learn
Attendees will see a live demonstration of the Aternity FPI Platform v5.0 and learn about the latest innovative capabilities for closing the visibility gap and driving winning performance including\:
• Web 2.0\, .Net\, Java\, Thick Client\, VDI\, Citrix and Enterprise Outlook Monitoring
• How Frontline Performance Intelligence delivers fast Mean-Time-To-Repair (MTTR) for the toughest desktop application problems
• Advanced analytics that drives rapid response to performance issues
• Privacy Compliance and Massive Scalability for Ensuring Enterprise Readiness of your Application Performance Management (APM) strategic initiatives
Who Should Attend
• IT Operations Leaders
• Application Owners
• Desktop Engineers
• Help Desk Personnel • Application Architects
• Performance Engineers
• ITOs\, ISVs\, SaaS Providers\, SIs and LARs
Featured Speaker
Trevor Matz ~ President and CEO\, ATERNITY
Trevor Matz is the President and CEO of Aternity. Matz leads Aternity as the company scales to redefine end user experience management by providing the industry’s first frontline intelligence platform. Matz has built and led world class sales and marketing organizations for enterprise software and services companies globally. Prior to joining Aternity\, Matz served as worldwide managing director of Application Integration for InterSystems Corporation where he took Ensemble from launch through recognition as the #1 Integration Platform in HealthCare.
Learning different citations styles can be difficult. Learning how to cite in APA is challenging\, but what happens when we throw the Bluebook (a style and citation guide for legal materials) into the mix? Do these two citation guides contradict each other? Can they work together? Come to hear Brandy W. Kreisler\, Online Instructor explain how APA and the Bluebook work together.
This webinar will teach attendees the following\:
• How to avoid plagiarism through proper citation
• How to cite basic materials using APA
• How to cite basic legal materials using the Bluebook
• How APA and the Bluebook work seamlessly together in academic papers
This presentation is for beginning and experienced students alike. Students just learning how to cite using APA will benefit alongside experienced scholars who want to take their citation skills to the next level. Paralegal students are especially invited\, as they will be using the Bluebook in many of their classes.
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120125T190000Z DTEND;VALUE=DATE-TIME:20120125T190000Z UID:http://www.webinarcentral.net/content/managing-complex-supply-chain-ecosystem URL;VALUE=URI:http://www.webinarcentral.net/content/managing-complex-supply-chain-ecosystem SUMMARY:Managing the Complex Supply Chain Ecosystem DESCRIPTION:Today’s manufacturing industry is a complex global ecosystem\, consisting of original equipment manufacturers\, strategic partners\, and multiple tiers of small and medium sized enterprises. Whether you make drugs\, devices\, biologics\, food or electronics you are responsible for your suppliers. If a supplier makes a mistake\, it’s you the FDA comes after. This webinar\, co-sponsored by Sparta Systems and Quality Digest\, is designed to cover Supplier Quality Management (SQM) from every angle. Dirk Dusharme\, Editor in Chief at Quality Digest will host the interactive session and Matthew Littlefield\, President and Principal Analyst at LNS Research\, will present research on best practices and industry trends that impact how leading manufacturers manage supplier quality.
Participate in an interactive webinar and have your questions answered on how Enterprise Quality Management Solutions (EQMS) can assist in supplier on-boarding\, and ongoing supplier maintenance. Industry trends and best practices will also be discussed for managing supplier audits\, supplier nonconformance management\, supplier corrective action request (SCAR) management\, and supplier rating/score-carding. Finally\, the benefits of a robust supplier quality management program will be discussed with a focus on improved revenue growth\, profitability\, product quality\, new product introductions\, and customer satisfaction.
About Sparta\:
Sparta Systems' quality management software\, TrackWise\, provides flexibility for company-specific quality management solutions.
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120125T200000Z DTEND;VALUE=DATE-TIME:20120125T200000Z UID:http://www.webinarcentral.net/content/art-therapy-and-anxiety-disorders URL;VALUE=URI:http://www.webinarcentral.net/content/art-therapy-and-anxiety-disorders SUMMARY:Art Therapy and Anxiety Disorders DESCRIPTION:This webinar is designed to educate participants about art therapy and provide practical skills for effective assessment and intervention with clients experiencing symptoms of anxiety.
Full Description\:
Practical assessment and intervention skills for treatment of anxiety through art therapy
This webinar is designed to educate participants about art therapy and provide practical skills for effective assessment and intervention with clients experiencing symptoms of anxiety. Demonstrations of art therapy techniques will advance the participants' understanding of the bio psychosocial perspective of many of the disorders that fall under the category of \\"anxiety\,\\" including phobias\, PTSD\, panic\, as well as sleeping and eating disorders. Significant attention will be paid to treatment interventions with numerous opportunities for hands-on art-based techniques.
Course Includes\:
Live Q&\;A
Presentation Handout
Post session recording access
CE Credit
What You Will Learn\:
Discover an alternative method of communicating with clients suffering with anxiety—including PTSD\, Phobias\, Acute Stress\, Eating Disorders\, Sleep Disorders\, and Panic Attacks
Identify effective Art Therapy techniques and learn how to implement them in session
Examine the therapeutic power that art provides in reducing stress and understanding fears
Acquire skills for assessing and treating anxiety
Discuss various art tasks and experience the healing process to promote coping skills in life
Your Presenter\:
PAMELA M. HAYES\, MFT\, LMHC\, ATR-BC\, is an artist and a registered and board certified Art Therapist. She is licensed as a Marriage and Family Therapist and Mental Health Counselor and is currently in private practice in Los Angeles\, California. Ms. Hayes developed the art therapy program at the Rhode Island School of Design–Continuing Education. For the past 15 years\, Ms. Hayes has worked in numerous psychiatric settings with a variety of clients. Currently\, her focus includes families\, couples\, adults and children struggling with mood and anxiety disorders\, addiction\, eating disorders\, abuse and grief-related issues. Ms. Hayes has an undergraduate degree in Fine Arts from Parsons School of Design in New York City and a graduate degree in Marriage and Family Therapy and Art Therapy from Notre Dame de Namur University in Belmont\, California. For more information about Ms. Hayes\, please visit her website at\: www.hayesarttherapy.com.
Disclaimer\:
This event qualifies for one CE credit. Only registered attendees will have access to CE. A Cross Country Education web account is required to attend. There is no charge for a CCE web account. It is recommended that you join the meeting 15 to 20 minutes early. Speaker phone sound quality is poor and it is recommended that they not be used to listen to the event.
Technical requirements\:
To view this webinar you will need to download the WebEx Application. You will be prompted to download it when you first enter the site. To save time\, you can setup prior to the meeting by following this link\: https\://apidemoeu.webex.com/apidemoeu/meetingcenter/mcsetup.php
Who Should Attend\:
Marriage and Family Therapists\, Licensed Professional Counselors\, Social Workers\, Psychiatric Nurses\, Drug and Alcohol Abuse Counselors\, Pediatricians\, Physicians\, Art Therapists\, Pastoral Counselors\, Guidance Counselors\, Youth Pastors\, Youth Counselors\, Educators
Science and STEM studies can make all the difference in a person’s life. Just ask Scott Parazynski\, M.D. – a former NASA astronaut\, doctor and adventurer. Scott’s resume is jam packed with stunning accomplishments ranging from exploring outer space via five Space Shuttle missions to conquering Mt. Everest to serving as Chief Technology Officer and Chief Medical Officer of The Methodist Hospital Research Institute (and so much more).
Join us for an exclusive 30-minute webinar\, where Scott will share his dynamic life experiences and explain how they all tie back to having a science and STEM background. He will even take questions from viewers. In case you can’t join us\, don’t worry. We’ll record the webinar and post it in our online community at www.conradawards.org so you can watch at a later date.
Register here\: https\://www3.gotomeeting.com/register/995535542
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120126T180000Z DTEND;VALUE=DATE-TIME:20120126T180000Z UID:http://www.webinarcentral.net/content/computer-system-validation-step-step-webinar-globalcompliancepanel URL;VALUE=URI:http://www.webinarcentral.net/content/computer-system-validation-step-step-webinar-globalcompliancepanel SUMMARY:Computer System Validation\: Step-by-Step - Webinar By GlobalCompliancePanel DESCRIPTION:This webinar will give a good understanding of FDA requirements for computer system validation and provide steps for cost-effective implementation.
The validation of computer system has been an FDA requirement since more than 20 years. Nevertheless companies have problems with implementation. This is proven through many FDA warning letters related to software and computer system validation\, especially in the last three years. Validation professionals know the principles but have problems with implementation\, especially with the development of protocols.
Reference material for easy implementation\:
SOPs\: Validation of Commercial Off-the-Shelf Computer Systems
Checklist\: Using computers in FDA regulated environments
Validation templates and examples
Areas Covered in the Session\:
US FDA and EU requirements and enforcement practices
Learning from recent FDA 483's and warning letters
Selecting the right validation model\: qualification vs. verification
Eight fundamental steps for computer system validation
Structure and example of a validation plan
Justification and documentation of risk levels
Example qualification document for suppliers of commercial systems
Examples for requirement and functional specifications?
Example for IQ protocols
OQ test protocols\: development\, execution\, approval - examples
Documentation of ongoing performance
Validation of existing systems
Structure and example of a validation report
Step-by-step case studies from laboratories and manufacturing for easy implementation
Who Will Benefit\:
IT managers and system administrators
QA managers and personnel
QC and Lab managers
Validation specialists
Regulatory affairs
Training departments
Documentation department
Consultants
Price List\:
Live \: $245.00
Corporate live \: $995.00
Recorded \: $295.00
webinars@globalcompliancepanel.com
http\://www.globalcompliancepanel.com
Phone\: 800-447-9407
Fax\: 302-288-6884
Overview \: In this 60 minute webinar\, Tamara shares her Virtual Workplace experience inside of Fortune 500 organizations.
Every organization should be prepared work in a virtual workplace. The preparation will include training and coaching employees to be successful in the virtual workplace (which is not about the selection of specific individuals or technology).
Why you should attend\: Managers and employees need to remain relevant by upgrading their skills to incorporate the process and technology necessary to manage effective virtual workplace environments.
The Virtual Workplace is fast becoming more the rule than the exception in organizations. As the workplace is changing and we recognize that \\"work is something that we do and not a place that we go\\"\, we must ensure that our employees are trained to thrive in the Virtual Workplace.
Areas Covered in the Session\: The agenda topics for this webinar include great information as well as a road map for success.
Why a competent on-site employee makes a competent Virtual Employee
Which is more successful for the organization? Employees are selected for the Virtual Workplace or employees are trained and coached to be successful.
What training is necessary to prepare employees to thrive in the Virtual Workplace?
How do we prepare employees for the Virtual Workplace?
What are employee responsibilities? (Virtual Workplace is not a Child Care Solution!)
What if the transition to the Virtual Workplace is not successful for some employees? Dealing with the Challenges!
Who Will Benefit\:
All levels of managers from the newly appointed to the executive level
Human Resources
Telework Administrators
Why you should attend\:
The HIPAA Security Rule\, in place and as proposed in amendments going into effect in 2011\, calls for all Covered Entities and Business Associates\, and their subcontractors\, to be in compliance with provisions protecting all kinds of electronic protected health information\, including the adoption of a complete set of information security policies and procedures.
While many entities have gone through the processes necessary for HIPAA Security Rule compliance\, many are only partially in compliance and have not adopted the policies and procedures necessary for compliance. Many may be doing many of the right things for compliance\, but have not documented their policies and procedures and compliance activities as required. And many may be exposing themselves to potential breaches of security because of inadequate\, undocumented security practices\, policies\, and procedures.
Now there are new\, increased penalties for HIPAA violations and a new\, random auditing process is being implemented so that HIPAA covered entities will be subject to reviews by the US Department of Health and Human Services' Office for Civil Rights even if no one files a complaint. And with new technologies like smart phones and portable media being added to the mix\, new vulnerabilities require new policies and procedures to avoid problems with audits and breaches.
If you haven’t done what’s required under the HIPAA Security Rule\, you could be liable for willful neglect penalties that begin at $10\,000 minimum and go up from there. You need the proper protections to secure protected health information\, and the necessary documented policies and procedures\, as well as documentation of any actions taken pursuant to your policies and procedures.
What's more\, with the breach notification regulations established in 2009\, the costs of not properly securing your data have increased dramatically. With the ever-increasing use of electronic records and systems\, and changes in how you do business\, now is the time to review and renew your information security program\, make sure you have the policies you need\, and avoid violations and penalties for non-compliance. Having the right policies and procedures in place can help prevent problems\, and show that you've been doing your best even if a problem arises.
Areas Covered in the Session\:
Find out what the requirements for policies and procedures are and why they're a good thing.
Learn how having good policies and procedures and good documentation can make compliance easier.
Learn the set of policies that need to be included in four groups of policies\: Information Security Management Process\, Access Controls\, Data Management\, and the Information System User Policy.
Learn how to use your policies and procedures\, and the documentation of use of your policies and procedures\, to satisfy audit requirements and avoid penalties.
Find out about scaling your policies to fit your organization - one size does not fit all!
Find out how well-organized policies and procedures make audits easier.
Learn with the significant penalties are for non-compliance with policy and procedure requirements.
Find out what are the first steps to take in developing your policies and procedures for HIPAA Security compliance.
Who Will Benefit\:
Compliance director
CEO
CFO
Privacy Officer
Security Officer
Information Systems Manager
HIPAA Officer
Chief Information Officer
Health Information Manager
Healthcare Counsel/lawyer
Office Manager
Contracts Manager
Price List\:
Live \: $195.00
Corporate live \: $695.00
Recorded \: $245.00
webinars@mentorhealth.com
http\://www.mentorhealth.com
Phone\: 800-447-9407
Fax\: 302-288-6884
This webinar on Potency Bioassays will show how to implement the parameters described in the new USP Bioassay suite to deliver compliant assays for Phase I/II\, Phase III and commercial products.
Why Should You Attend\:
Potency bioassays are a regulatory requirement for release and stability testing of all biopharmaceutical products. Guidelines have remained vague on bioassay expectations due to the large assortment of mechanisms\, end points and targets required for these assays. An additional obstacle is the perceived variability of the methods resulting in unacceptable failure rates due to unreliable accuracy\, precision and parallelism expectations. The draft USP Bioassay suite consists of the following new chapters\: USP 1032\, 1033 and 1034). These chapters will be finalized soon and are already being accepted as a coherent data-driven approach to develop\, analyze and validate potency assays.
This presentation provides logical advice on how to implement the parameters described in the new USP Bioassay suite to deliver compliant assays for Phase I/II\, Phase III and commercial products. We will also review critical validation parameters and use case studies to highlight the benefits of using the new chapters.
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120126T160000Z DTEND;VALUE=DATE-TIME:20120126T160000Z UID:http://www.webinarcentral.net/content/developing-social-media-policy-clear-guidelines-prevent-or-reduce-employment-related-problem URL;VALUE=URI:http://www.webinarcentral.net/content/developing-social-media-policy-clear-guidelines-prevent-or-reduce-employment-related-problem SUMMARY:Developing a Social Media Policy\: Clear Guidelines to Prevent or Reduce Employment-Related Problems - Webinar By TrainHR DESCRIPTION:Overview \: This webinar will discuss in detail how social media has changed the workplace forever\, both in productivity and how information is managed. It will be discussed how most corporate personnel departments are struggling to keep up with the times and what they are doing to stay current.
This webinar will also cover employees common law privacy rights in information about their personal lives\, health\, finances\, sex lives\, off-duty activity and personal email and phone accounts. Discussion will include how social media can be instrumental in the collision of an employee’s work life and personal life. The presenter will guide you on issues to consider when creating a social media policy.
Why you should attend\: Social media use in the workplace has become a fact of life for employers and is here to stay. Many companies have even come to embrace social networking sites\, such as Facebook and Twitter\, blogs and other web-based tools for client development\, recruiting\, branding and other business needs. Employees' social media use\, both inside and outside the workplace\, remains a challenge for employers\, promising both business opportunities and risks.
Areas Covered In the Session\:
Overview of changes in social media in the workplace
Legislation protecting employee rights
National Labor Relations Board influence in social media activity at the workplace
How to write a social media policy to include corporate culture and values
How to ensure employee rights are protected
Current court cases and outcome on workplace social media claims
Who will benefit\:
HR Directors
HR Managers
Employee Relations Managers
Business Owners
Learn to hold your vision inspite of negative intrusive thoughts
If you feel like you have been doing things so right\, but don’t know what’s going wrong\, this free webinar is for you!
Do you have something coming up you’d like to attract more money for?
Are you wondering if you can actually turn things around?
Listen in on a live coaching call that will help you get back into alignment with source energy\, your soul\, so that Your Abundance Flows More Effortlessly!
43 ATTRACT MONEY TIPS! Stick around until the end of the free webinar and receive THE 43 “ENERGY STATES” THAT ATTRACT AND REPEL MONEY .pdf (As my gift to you for having fun with it and allowing yourself to receive!)
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120126T190000Z DTEND;VALUE=DATE-TIME:20120126T190000Z UID:http://www.webinarcentral.net/content/effective-psychological-consultations-bariatric-surgery-client-0 URL;VALUE=URI:http://www.webinarcentral.net/content/effective-psychological-consultations-bariatric-surgery-client-0 SUMMARY:Effective Psychological Consultations for the Bariatric Surgery Client DESCRIPTION:The psychological evaluation is a critical\, often mandatory step. This course helps mental health professionals become more adept when assessing and consulting bariatric surgery candidates.
Full Description\:
Is my patient prepared for weight loss surgery?
Bariatric surgery as a means of weight loss has become increasingly popular over the past decade\, so much so that it is now deemed as a medical necessity in most cases of morbid obesity. The FDA is now making the recommendation that
weight loss surgery be available to those with a lower BMI (BMI>\;30). With a potential growing number of these surgeries\, there is a significant co-morbidity of psychological factors that need to be assessed and identified before patients
can be approved for surgery.
The psychological evaluation of the bariatric surgical candidate is considered to be a most critical and necessary step in the pre-surgical process. Mental health professionals are being sought with increased demand\, not only in the
evaluation of surgical candidates\, but also to treat patients who are not yet deemed ready for surgery. This course is designed to review the process of gastric bypass procedures\, and help mental health professionals at all levels become
more adept in providing services of assessment and consultation.
Course Includes\:
Live Q&\;A
Presentation Handout
Post session recording access
CE Credit
What You Will Learn\:
Evaluate candidates for bariatric surgery and psychological contraindications
Determine which populations need additional therapeutic work prior to the surgical process
Gain a better understanding of the emotional and psychological risks and benefits of bariatric surgery for patients with morbid obesity
Your Presenter\:
MICHAEL WETTER\, PsyD\, DAPA\, is a clinical psychologist with 18 years of experience and serves as the Psychological Services Coordinator for the Center for Weight Loss at Cedars-Sinai Medical Center in Los Angeles where he performs pre-
surgical evaluations and assessment of patients undergoing bariatric surgery. He earned a master's degree in Counseling Psychology from Northwestern University\, a Doctorate in Clinical Psychology from Pepperdine University\, and completed
a formal post-doctoral fellowship at the Kaiser Permanente Medical Group. Dr. Wetter has also acted as a consultant for publications such as the Washington Post\, the Boston Globe\, the Atlanta Journal-Constitution\, Men's Health magazine\,
Forbes magazine\, Prevention magazine\, and Redbook magazine.
In addition\, Dr. Wetter is a Diplomate of the American Psychotherapy Association\, has served as an adjunct professor at numerous universities\, and is a guest lecturer nationwide training psychologists and other mental health
professionals.
Disclaimer\:
This event qualifies for one CE credit. Only registered attendees will have access to CE. A Cross Country Education web account is required to attend. There is no charge for a CCE web account. It is recommended that you join the meeting
15 to 20 minutes early. Speaker phone sound quality is poor and it is recommended that they not be used to listen to the event.
Technical requirements\:
To view this webinar you will need to download the WebEx Application. You will be prompted to download it when you first enter the site. To save time\, you can setup prior to the meeting by following this link\:
https\://apidemoeu.webex.com/apidemoeu/meetingcenter/mcsetup.php
Who Should Attend\:
Psychologists\, Licensed Professional Counselors\, Psychiatric Nurse Practitioners\, Psychiatric Nurse\, Mental Health Nurses\, Social Workers\, Marriage and Family Therapists\, Gastroenterology Nurses\, Physician Assistants\,Physicians\,
Psychiatrists\, Primary Care Nurses
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120127T130000Z DTEND;VALUE=DATE-TIME:20120127T190000Z UID:http://www.webinarcentral.net/content/full-day-virtual-seminar-china-compliance-processes-life-science-products URL;VALUE=URI:http://www.webinarcentral.net/content/full-day-virtual-seminar-china-compliance-processes-life-science-products SUMMARY:Full Day Virtual Seminar - China\: Compliance Processes for Life Science Products DESCRIPTION:This 6-hr China life science compliance based webinar will discuss the regulatory structure and requirements for compliance with Chinese SFDA regulations for Pharmaceuticals\, Medical Devices\, Biologics and Combination Products.
Why Should You Attend\:
China has been improving its regulatory regime governing the food and pharmaceutical industry in recent years. In 2010\, by promulgating the amended GMP and amending GLP\, GCP\, GSP and other regulations\, China will further align the country with international standards of practice. For manufacturers and distributors of drugs and medical devices in China\, it is important to pay close attention to the pace at which SFDA implements these changes and to make changes to their standard operating procedures when necessary to ensure compliance with the evolving regime.
This 6-hr course specifically focuses on the overall regulatory compliance requirements and procedures for Pharmaceuticals\, Medical Devices\, Biologics and Combination Products in China. The course will cover topics relating to pre-clinical and clinical requirements\, as well as\, addressing the structure of the regulatory agencies in China. Content will also include descriptions of the methods by which regulators in the SFDA process filings and registrations and what is expected in the authorization and dossier maintenance of licensed products.
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120127T160000Z DTEND;VALUE=DATE-TIME:20120127T170000Z UID:http://www.webinarcentral.net/content/preparing-fda-gcp-inspections-%E2%80%93-essentials-sponsor-companies URL;VALUE=URI:http://www.webinarcentral.net/content/preparing-fda-gcp-inspections-%E2%80%93-essentials-sponsor-companies SUMMARY:Preparing for FDA GCP Inspections – Essentials for Sponsor Companies DESCRIPTION:Why Should You Attend\:
GCP inspections\, particularly those involving FDA investigators\, are often seen as an intimidating and adversarial experience\, as opposed to a useful process for improving quality and ensuring compliance. However\, there are steps you can take to make the process less stressful\, and to avoid the most common issues arising during these inspections.
In this webinar\, our speaker\, a former FDA investigator\, shares insight on how FDA prepares for an inspection\, and reviews GCP regulations and FDA guidelines used for inspections. The presentation provides attendees from sponsor companies (pharmaceutical\, biotech\, device/diagnostics) and clinical sites with practical information on how to utilize quality improvement methods to effectively prepare for FDA GCP inspections.
Areas Covered in the Seminar\:
- The most common FDA inspection deficiencies noted among sites and sponsors.
- Overview of GCP regulations and FDA guidelines used for inspections.
- The areas that are reviewed during GCP inspections.
- Inspection documentation and proper follow-up procedures.
- Effective techniques and tools that can used to prepare for GCP inspections.
Discover a New Way to Earn Profit
Whether you are looking to earn non-dues revenue or create an additional income source\, offering paid webinars is an easy way to profit from your knowledge. This webinar explores ways to convert your valuable\, industry-specific knowledge into something tangible – and profit from it.
What You Will Learn\:
• Various types of revenue generating webinars
• Tips to create value from content
• Marketing techniques to attract audiences
• Components required to offer CEU credits
Who Should Attend\:
• Professionals who wish to leverage their industry knowledge for profit
• Association Executives who are looking to earn non-dues revenue
• Anyone who has content that is valuable to others
All Attendees will receive\: a copy of \\"Costs of Putting Together a Webinar”
About the Presenter\:
Don Cameron\, Marketing Strategist and founder of Interactive Telesis and ConferTel\, has helped hundreds of organizations generate non-dues revenue by delivering educational webinars to their members in addition to helping businesses use an educational marketing approach to cost-effectively generate qualified sales leads.
Why Should You Attend\:
As standards continue to evolve\, this introductory course is designed to provide life sciences professionals with a foundation in the fundamental concepts of the electronic Common Technical Document (eCTD) in order to facilitate awareness and understanding of the quickly evolving regulatory landscape.
This course provides a high level\, practical approach to understanding the organization\, structure\, and technical aspects of the eCTD and highlights key considerations for submission management in terms of both individual submission preparation and lifecycle management over time.
Agenda\:
10\:00am PST to 11.30am PST Session 1.
11\:30am PST to 11.45am PST Break.
11\:45am PST to 1.15pm PST Session 2.
Learning Objectives\:
- Review the process that led to the development of the CTD.
- Understand eCTD concept and structure.
- Become familiar with the underlying technology used in the eCTD.
- Understand how the eCTD organizes study files.
- Learn about lifecycle management advantages of the eCTD.
- Get a glimpse into the challenges and logistics of submission management.
Short Description\:
This one-hour webinar provides attendees with a definition of art therapy\, its benefits\, &\; how it differs from verbal therapy. Case studies will be presented to assist attendees in identifying indicators &\; key images in their clients' art.
Full Description\:
Identify expressions of mood through your clients' drawings and paintings
This webinar program provides definitions of what Art Therapy is and how it differs from verbal therapy. The role of art-making in diagnosis and treatment is addressed through assessment by examining age-appropriate drawing skills and the symbolism of images that have personal meaning to our clients. In addition\, this course examines art-making as personal growth and its therapeutic benefits. The attendees will learn specific indicators to look for in their clients' art work and how to identify key images through the presentation of several case studies. Through these case studies the participants will identify how clients can express their mood through drawing and painting. Psychological and behavioral problems\, such as regression and impairments\, will be identified through the symbolism in clients' art work.
Course Includes\:
Live Q&\;A
Presentation Handout
Post session recording access
CE Credit
What You Will Learn\:
Discover a new method of communicating with clients
Examine effective Art Therapy techniques
Understand the therapeutic power that art provides
Acquire skills for assessing the client's stress level
Discuss current research as it relates to Art Therapy and its effectiveness with clients
Your Presenter\:
PAMELA M. HAYES\, MFT\, LMHC\, ATR-BC\, is an artist and a registered and board certified Art Therapist. She is licensed as a Marriage and Family Therapist and Mental Health Counselor and is currently in private practice in Los Angeles\,
California. Ms. Hayes developed the art therapy program at the Rhode Island School of Design–Continuing Education. For the past 15 years\, Ms. Hayes has worked in numerous psychiatric settings with a variety of clients. Currently\, her focus includes families\, couples\, adults and children struggling with mood and anxiety disorders\, addiction\, eating disorders\, abuse and grief-related issues. Ms. Hayes has an undergraduate degree in Fine Arts from Parsons School of Design in New York City and a graduate degree in Marriage and Family Therapy and Art Therapy from Notre Dame de Namur University in Belmont\, California. For more information about Ms. Hayes\, please visit her website at\: www.hayesarttherapy.com.
Disclaimer\:
This event qualifies for one CE credit. Only registered attendees will have access to CE. A Cross Country Education web account is required to attend. There is no charge for a CCE web account. It is recommended that you join the meeting 15 to 20 minutes early. Speaker phone sound quality is poor and it is recommended that they not be used to listen to the event.
Technical requirements\:
To view this webinar you will need to download the WebEx Application. You will be prompted to download it when you first enter the site. To save time\, you can setup prior to the meeting by following this link\:
https\://apidemoeu.webex.com/apidemoeu/meetingcenter/mcsetup.php
Who Should Attend\:
Marriage and Family Therapists\, Licensed Professional Counselors\, Social Workers\, Psychiatric Nurses\, Drug and Alcohol Abuse Counselors\, Pediatricians\, Physicians\, Art Therapists\, Pastoral Counselors\, Guidance Counselors\, Youth Pastors\, Youth Counselors\, Educators
This 3-hr virtual seminar will take a deeper look at your recruiting practice and review the objective for affirmative action as it relates to this function in terms of ensuring compliance. The session also features a discussion about how to make the most of your recruiting technology so that you are prepared to meet the OFCCP’s recently heightened enforcement efforts.
Why Should You Attend\:
Over the last 6 years\, we seen the OFCCP become better funded\, more sophisticated\, and more motivated than ever to enforce affirmative action rules. Further\, the changes initiated by the OFCCP have presented the greatest challenges for contractors with respect to compliance. In this new enforcement environment\, government contractors are well advised to be prepared for more audits and more settlements\, as there will be an aggressive increase in the OFCCP’s affirmative action enforcement efforts. From a risk perspective\, your recruiting practices pose the greatest legal liability for your organization.
In this 3-hr training\, we’ll take a practical look at what you should be doing now from a recruiting perspective to get and stay in compliance with the directives of a newly attentive OFCCP.
We will specifically focus on your recruiting efforts from common missteps\, to enforcement traps. You won’t want to miss the plethora of practical steps you can take now to correct the most common issues as well as what you can do with technology moving forward so that you are better positioned for success during an audit (The session features a discussion by guest speaker\, Sylvia Dahlby\, about how to make the most of your recruiting technology so that you are prepared to meet the OFCCP’s recently heightened enforcement efforts).
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120130T150000Z DTEND;VALUE=DATE-TIME:20120130T180000Z UID:http://www.webinarcentral.net/content/3-hr-virtual-seminar-boot-camp-untangling-fmla-adaaa-gina-and-workers-compensation-laws URL;VALUE=URI:http://www.webinarcentral.net/content/3-hr-virtual-seminar-boot-camp-untangling-fmla-adaaa-gina-and-workers-compensation-laws SUMMARY:3-hr Virtual Seminar - Boot Camp\: Untangling the FMLA\, ADAAA\, GINA\, and Workers Compensation Laws DESCRIPTION:This 3-hr training will show how you can deal with an employee who suffers from an on the job injury and his/her leave requirements trigger rights under the FMLA and the newly amended ADAAA. You will learn when you can terminate this individual\, if ever and make sure you are complying with all legal requirements when it appears that compliance with one law may mean violating the other.
Why Should You Attend\:
One of the most difficult task facing human resource professionals today is how to deal with the employee who suffers from an on the job injury and his/her leave requirements trigger rights under the Family and Medical Leave Act and the newly amended Americans with Disabilities Amendments Act. Some companies have policies that require termination after an individual has been on leave for a period of time. Yet\, the EEOC says such policies may be illegal under the ADAAA. Yet\, every human resource professional must face the inevitable question of whether a person on leave should be removed from the payroll. It is frustrating\, however\, when the time has come only to find out that the time out wasn’t properly designated.
Attend this 3-hr virtual workshop to learn how you can navigate these murky challenges and be legally compliant while doing it.
Areas Covered in the Seminar\:
- The basic of workers' compensation and why it may trigger rights under the Family and Medical Leave Act.
- When is a workers' compensation injury a “serious health condition” under the Family and Medical Leave Act?
- When is a workers' compensation injury a disability under the Americans with Disabilities Act?
- When the ADAAA may require you to offer light duty as an accommodation?
- When the ADAAA may require you to extend leave requirements beyond state workers' compensation laws or beyond FMLA?
- How to get the medical information you need without violating GINA\, FMLA\, and the ADAAA?
- How what you say in documentation can hurt you in court – are you using the word “disability” interchangeably? Why it has different meanings depending on the law?
This 3-hr virtual seminar on HIPAA Security Rule Compliance and Risk Analysis will present an organized and simple approach to perform an effective Information Security Risk Analysis and reduce your organization’s exposure to breaches and penalties. Examples of real situations will be presented and new procedures to reduce risks will be discussed.
Why Should You Attend\:
This session will present the background of the regulations that call for information security risk analysis and show how it fits in to an overall information security management process. The risk analysis process will be presented within the context of the overall risk prioritization and risk mitigation process\, using an example.
Areas of high risk\, as identified by respected industry organizations\, will be identified to ensure that the most significant risks are discovered and adequately prioritized. The risk analysis process will be applied to a simplified example in order to relate the process to a real situation and drive home the usefulness of the process.
Attendees will gain insights into the management of risks and reduction of exposure to breaches and penalties\, and will be able to implement new procedures that will reduce risks immediately.
END:VEVENT BEGIN:VEVENT DTSTAMP;VALUE=DATE-TIME:20120524T182819Z DTSTART;VALUE=DATE-TIME:20120131T160000Z DTEND;VALUE=DATE-TIME:20120131T173000Z UID:http://www.webinarcentral.net/content/particulates-biological-products-why-test-them-and-what-are-new-reporting-requirements URL;VALUE=URI:http://www.webinarcentral.net/content/particulates-biological-products-why-test-them-and-what-are-new-reporting-requirements SUMMARY:Particulates in Biological products. Why test them and what are the new reporting requirements DESCRIPTION:The FDA has requested BLA sponsors to submit sub-visible particulate data for Well Characterized Protein Products in the clinical and commercial phases. The evidence continues to accumulate that particulates increase immunogenicity of the protein product. The regulatory requirements for testing Biologics for Particulates continue to evolve.
Why Should You Attend\:
Proteinaceous Particulates in Biologics injectibles can arise from the aggregation of the protein product and can be induced by silicone droplets\, metal particles and glass particles. Aggregates in protein products present a safety concern because they increase the immunogenicity of the product. The FDA has therefore requested BLA sponsors to present sub-visible particulate data at the clinical and commercial stage. The initially identified method –gap for suitable techniques for testing particles in the 0.2 - 10 micron range is being rapidly filled by new technologies.
Whether the aggregates found during in vitro testing truly reflects the quantity and type of aggregates in vivo is not clear and continues to be debated. Nevertheless this debate has increased the scrutiny of reviewers on the testing and reporting of particulates in Protein Therapeutics.
This updated webinar addresses recent discussions in the industry related to testing sub-visible particulates in Biologics injectibles. Recent FDA expectations for reporting data will be discussed. Methods for characterization and routine testing of particulates\, their advantages and limitations will be discussed. Case studies where the various methods have been used for characterization of the sub-visible particles will be discussed.
Areas Covered in the Seminar\:
- Why test for sub-visible particulates in protein therapeutics.
- Current expectations for testing for particulates in protein therapeutics.
- USP method for particulate testing in injectibles.
- Commonly used 'work-horse' methods for particulates.
- Characterization methods for particulates.
- Newly emerging methods for subvisible particulates.
This webinar will cover how to develop and implement a formal program on telecommuting for companies who are considering it and how to review and formalize current practices for companies who already have a program.
Why Should You Attend\:
More and more companies are allowing employees to perform their work from a remote worksite ranging from an occasional occurrence to a regular full-time schedule.
This webinar contains an overview of how to develop a policy\, who or what positions would be eligible\, alternative work arrangements\, the approval process\, rules of operation\, compensation and eligible expenses\, equipment considerations and support\, and effective communication practices. We will cover the business case for telecommuting as well as the advantages and disadvantages. This session will also cover how to develop a proposal to adopt either a full telecommuting plan or hybrid and how to measure\, justify and communicate results.
Areas Covered in the Seminar\:
- Presenting the Business Case for Telecommuting.
- How to Determine Eligibility and Participation?
- Support Needs for Work at Home.
- Addressing Legal Issues\, such as hours worked\, safety and confidentiality.
- Compensation and Expenses.
- Developing Policies and Procedures on Telecommuting.
- Evaluating the Program and Measuring Results.
This topic will focus on how health care providers can stay out of trouble. Too often health care providers concentrate on providing services and neglect any effort to avoid penalties for fraud and abuse\, leaving them exposed to punitive actions.
State &\; federal agencies which oversee healthcare programs are increasing their efforts to eliminate fraud and abuse. Resulting in close scrutiny of provider practices.
Areas Covered in the Session\:
Have an active compliance plan.
Never bill services you did not provide
Never conduct any business that results in unwarranted services
Never certify any services unless they are necessary &\; appropriate and in line with the diagnosis and well being of patients.
Never allow referring providers to extend services not authorized.
Never use codes that do not refer to the actual services provided.
Never change medical records when challenged by a payer or add subtract or try to improve documentation.
Who Will Benefit\:
Health Care Professionals
Health Service Providers
Compliance Officers
CEO's
Corporate Attorneys
Price List\:
Live \: $195.00
Corporate live \: $695.00
Recorded \: $245.00
webinars@mentorhealth.com
http\://www.mentorhealth.com
Phone\: 800-447-9407
Fax\: 302-288-6884
Short Description\:
Explore Face Blindness\, also called Developmental Prosopagnosia\, new research to better understand its relationship with ASD\, and how to help children recognize the faces and emotions of their families\, teachers\, and friends.
Full Description\:
Why Can’t I Recognize Faces?
Researchers have discovered that 2–3% of the world’s population cannot recognize the faces of others and their own face. This “face blindness” is called Developmental Prosopagnosia and is thought to be a genetic neurobiological disorder. Recent discoveries show that Prosopagnosia is highly comorbid with Autism Spectrum Disorders (ASD) and have prompted the DSM-5 committee to consider adding problems recognizing faces to the symptoms related to ASD. Additionally\, researchers have expanded the definition of Developmental Prosopagnosia to include those who have trouble recognizing facial expressions. Those with ASD\, likewise\, often have great difficulty.
This webinar will review the current research and discuss specific ways of screening for Developmental Prosopagnosia in children with and without ASD. Empirically proven treatment methods will be discussed and specific techniques of accommodating children will be outlined.
Course Includes\:
Live Q&\;A
Presentation Handout
Post session recording access
CE Credit
What You Will Learn\:
Examine the latest research on Face Blindness\, also known as Developmental Prosopagnosia\, and how it can affect children with Autism Spectrum Disorders
Describe the symptoms and methods of screening
Discuss the neuroanatomy of Developmental Prosopagnosia
Identify methods of accommodating children with Developmental Prosopagnosia in the classroom
Outline evidence-based techniques and describe technologies that can aid in treatment
Your Presenter\:
KEVIN T. BLAKE\, PhD\, P.L.C.\, is a licensed psychologist and author with over 20 years of experience as a nationally recognized authority on learning disorders and ADHD in children\, adolescents\, and adults. This interest spurred from his own struggles overcoming a reading disorder/dyslexia and hearing impairment.
Dr. Blake serves as a member of the American Psychological Association\, International Dyslexia Association\, Children and Adults with Attention Deficit Disorders\, Learning Disabilities Association\, and the National Attention Deficit Disorder Association and was a 1991 delegate to the National Institute for Literacy’s “LEAD 2000 Congress\,” where he advised Congress on diagnostic and remediation issues.
Disclaimer\:
This event qualifies for one CE credit. Only registered attendees will have access to CE. A Cross Country Education web account is required to attend. There is no charge for a CCE web account. It is recommended that you join the meeting 15 to 20 minutes early. Speaker phone sound quality is poor and it is recommended that they not be used to listen to the event.
Technical requirements\:
To view this webinar you will need to download the WebEx Application. You will be prompted to download it when you first enter the site. To save time\, you can setup prior to the meeting by following this link\: https\://apidemoeu.webex.com/apidemoeu/meetingcenter/mcsetup.php
Who Should Attend\:
Psychologists\, Social Workers\, Licensed Professional Counselors\, Marriage and Family Therapists\, School
Psychologists\, Guidance Counselors\, Psychiatric Nurses\, Nurses\, Psychiatric Nurse Practitioners\, Pediatric
Nurse Practitioners\, Case Managers\, Clergy\, School Administrators\, Physicians\, Psychiatrists\, Mental Health
Administrators\, Special Education Teachers\, Alcoholism and Drug Abuse Counselors